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Our goal is to develop an effective work flow for analysis of intact proteins in a 
complex mixture using the LC-LTQ-Orbitrap XL. Intact protein analysis makes the 
entire sequence available for characterization, which allows for the identification of 
isoforms and post translational modifications. We focus on developing a method 
for top-down proteomics using a high-resolution, high mass accuracy analyzer 
coupled with bioinformatics tools. The complex mixtures are fractionated using 1-
dimensional reversed-phase chromatography and basic reversed- phase, and open 
tubular electrophoresis. The analysis of intact proteins requires various 
fragmentation methods such as collisional induced dissociation, high energy 
collisional dissociation, and electron transfer dissociation. This overall method 
enables us to analyze intact proteins, providing a better understanding of protein 
expression levels and post transitional modification information. We have used 
standard proteins to optimize HPLC conditions and to compare three methods for 
ion activation and dissociation. Furthermore, we have extended the method to 
analyze low mass proteins in MCF7 cytosol and in E. coli lysate as a model 
complex mixture. We have applied this strategy to identify and characterize 
proteins from extracellular vesicles (EVs) shed by murine myeloid-derived 
suppressor cells (MDSC). MDSCs suppress both innate and adaptive immune 
responses to tumor growth and prevent effective immunotherapy.  Recently some 
of the intercellular immunomodulatory effects of MDSC have been shown to be 
propagated by EVs.  Top-down analysis of intact proteins from these EVs was 
undertaken to identify low mass protein cargo, and to characterize post-
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Chapter 1: Introduction 
 
Protein Mass Spectrometry 
 
The word proteomics can be defined as the entire protein component 
expressed by a genome, or by a cell or tissue type, under a given condition.  The 
main subfields of proteomics analysis are characterization, which provides a survey 
of proteins present in a cell tissue or biofluid; differential proteomics, which 
provides identification of differentially expressed proteins in different 
physiological states; and functional proteomics, which provides identification of a 
group of proteins involved in specific functions.
1
 Proteomics focuses on the 
dynamic description of gene regulation. Thus it offers more information than a 
protein equivalent of DNA databases.
2
  In the  early history of proteomics, proteins 
were fractionated using two-dimensional polyacrylamide gel electrophoresis (2DE) 
followed by visualization using protein stains, such as Coomassie or silver stain, 
subsequently the protein spots were identified using mass spectrometry.
3
 Mass 
spectrometry (MS) has become a ubiquitously useful tool for proteomic research. It 
provides comprehensive knowledge about systems biology, including proteomic 
profiling, protein quantity, and post-translational modifications (PTMs) of cellular 
and organellar proteomes.
1
 Many different aspects of MS have led to its prominent 
position within the field of proteomics. The sensitivity of MS allows for routine 
identification of proteins in femtomole to high attomole range.
4




identify proteins with confidence is aided by mass measurement accuracy available 
using current MS technology. The accuracy is typically less than 50 parts per 
million (ppm) and is often less than 5 ppm.
5
 The ability of tandem MS to obtain 
partial sequence information enables confident bioinformatic identification of 
proteins and peptides in complex mixtures. In  recent years, protein and peptide 
fractionation methods coupled with various mass spectrometry technologies have 
evolved as the dominant tools in the field for protein identification.
6
 Mass 
spectrometry is a technique that measures the masses and relative abundances of 
atoms and molecules. In order to accomplish this, each mass spectrometer is 
composed of an ion source, an analyzer, and a detector. The ionizer generates gas 
phase ions from the sample.
1
 The analyzer separates those ions by mass/charge and 
allows for fragmentation of the precursor ion to create other, smaller ions. The 
detector records the ions and provides the signal to be interpreted by the instrument 
software. The typical mass spectrum has two important pieces of information, the 
mass-to charge ratio (m/z) and the relative abundance or intensity. The most intense 
signal is generally set at 100% and the other signals have their height plotted in 
proportion to this “base” peak.
1
 A common platform for analysis of complex 
protein mixtures consists of high pressure liquid chromatography (HPLC), 
electrospray ionization, and high resolution mass spectrometry. Complex mixtures 
are first fractionated by reverse phase HPLC, which is interfaced to an ion source 
of the mass spectrometer, where they are first ionized to acquire positive or 




detector based on m/z ratio and the ions makes contact with the detector the signals 





The three widely used methods in proteomic analysis are bottom-up 
proteomics, top-down proteomics, and middle-out proteomics.  
 
Bottom-Up Proteomics 
The most common approach used in proteomic analysis is the bottom-up 
method. Proteins are proteolytically digested into peptides prior to mass 
spectrometric analysis, typically using trypsin, which is an enzyme that hydrolyzes 
peptide bonds C-terminal of arginine and lysine residues, except when followed by 
proline. The peptides are fractionated using LC methods and fragmented using 
collisionally induced dissociation as a fragmentation technique. The fragment ion 
spectra are compared with the predicted spectra that are in silico–generated 
fragmentation patterns of the peptides from proteins in a user-defined database. The 
drawback of utilizing bottom up proteomic methods is that the proteins maybe 
identified on the basis of a limited number of peptides, low abundant peptides can 
be lost during chromatography and due to the complexity of the sample, and thus 
some peptides may not be analyzed in data dependent experiments. In addition, a 
single amino acid substitutions or an unexpected post translational modification can 
prevent identification of the peptide. Furthermore, even when a protein is 




sequence is only partially obtained, thus there is gain of information about 
proteoforms and PTMs of the proteins identified.
8
 
Top-Down Proteomics  
 The top-down approach in proteomics ionizes the whole protein in the 
mass spectrometer, fragments the protein, then matches the fragments against the 
database of fragment masses generated in-silico from a data base of intact protein 
sequences. A major advantage of top down methods is that performing an MS/MS 
experiment on an intact protein ion, in principle, makes the entire sequence 
available for complete characterization and localize any post-translational 
modifications on the protein.
9
 In addition, the method allows the identification of 
proteoforms, mutations and splice variants.
10
 For example, the two proteins 
thymosin beta-4 and thymosin beta-10 have very similar amino acid sequences, as 
shown in Figure 1. If these two proteins are present in a complex mixture that is 
digested using trypsin and peptide ETIEQEK is identified in the bottom up 
analysis, then it would be very difficult to confidently say if the peptide was 
identified from thymosin beta-4, thymosin beta-10 or both. Thus, using the top-
down methodology and recording the intact mass of the protein, it is possible to 
differentiate and identify two proteoforms present in the complex mixture. 




Figure 1: Protein sequences of (A) thymosin beta-10, (B) thymosin beta-4. The 





High resolution mass spectrometers are needed to resolve monoisotopic 
peak of the highly charged protein molecules. The instruments that provide high 
resolving power for intact proteins and their fragment ions are Fourier transform 
based instruments such as the Fourier transform ion cyclotron resonance (FTICR), 
and the hybrid LTQ Orbitrap, and high end time-of-flight (TOF) analyzers. These 
instruments usually employ ESI as an ionization technique for analysis of intact 
proteins with multiply charged ions for the same protein.
11
 The molecular weight of 
the intact protein is calculated on the basis of its multiply charged spectrum for 
ESI. During bioinformatics analysis the mass difference between the calculated and 
the measured mass of the protein is sufficient to indicate the presence of PTMs. 
Furthermore, fragment ion data generated by the top-down approach is 
unambiguously assigned to a particular protein whose precursor ion was selected 
for fragmentation, thus providing information about the complete sequence of the 
protein itself.
12
 The top-down method can integrate and support information 
obtained from bottom-up analysis, in particular regarding complete protein 
sequence and PTM localization, as well as any combination possibly existing 




The middle-out approach in proteomics is a compromise between bottom-




using the top-down strategy, it is difficult to perform the analysis on a LC time 
scale, especially for low abundant proteins. Middle-out analysis uses alternative 
enzymes for the cleavage of proteins to generate longer peptides than 
conventionally obtained peptides in bottom-up proteomics; usually peptides larger 
than 20 amino acid residues (5-10 KDa). These large peptides can sometimes 
provide information on PTMs. The larger peptides are generated using reagents 
such a CNBr or enzymes such as Lys-C, Asp-N, Glu-C. Additionally, microwave 
assisted acid cleavage on the aspartic acid residue also generates peptides with an 
extended mass range. The advantage of middle-out strategy, as opposed to bottom-





Fractionation Methods for Top-Down Proteomics  
Due to the complexity of biological samples, it is necessary to fractionate 
the complex mixtures prior to their measurement with mass spectrometry, so that 
the complexity of what is introduced to the mass spectrometer is compatible with 
the performance of the instrument. Among various separation modes available, 
electrophoresis and chromatography are most widely used at this time. For the top-
down approach, 2-DE
3
 is one of the most commonly used approaches for proteome 
analysis, because of its unparalleled resolving power. However, there are many 
downsides to using this approach. It is labor-intensive, and has low sensitivity, poor 




methodology is its  inability to investigate very hydrophobic/hydrophilic
14, 15
 and 
low copy number proteins
16,17
 in whole cell lysates.
18
   
In recent years, HPLC has become a popular liquid phase based separation 
technique. HPLC coupled with mass spectrometry has become an indispensable 
tool for proteomics due to its compatibility with ESI. Chromatographic separation 
of a protein mixture is based on the interaction of proteins with the stationary 
phase, and equilibration between adsorption on the stationary phase and in the 
mobile phase. High resolution separation prior to mass spectrometer analysis 
minimizes ion suppression and under-sampling associated with the analysis of 
highly complex proteomes.  In order to improve the separation capacity, detection 
sensitivity, and analysis throughput of micro- and nano-HPLC,  recent advances 
have been made by increasing column length, reducing inner diameter, using sub-
micrometer sized packing materials and monolithic columns.
19
 Successful detection 
by the mass spectrometer is closely related to the flow rate of the HPLC. Lower 
flow rates in the nanoliter ranges result in smaller eluent droplets, more charges per 
analyte molecule, and higher ESI efficiency. Most protein separations are 
performed with columns packed with packing material made of silica and operated 
with an reversed phase HPLC.
20
 The chemical and physical properties of a protein, 
such as hydrophobicity, length, net charge, and solubility influence the retention 
time and separation. From protein complexes to whole cell lysate, proteome 
analysis deals with highly complex mixtures, requiring more than one analytical 
dimension to achieve the high resolving power necessary for reliable analysis.
21
 




mixtures in a single analytical dimension. Consequently, multiple proteins, or 
peptides, enter the mass spectrometer at any given time, leading to fewer numbers 
of identifications. Multidimensional methods, having orthogonal separation modes, 
are expected to overcome the problem of insufficient resolution in the analysis of a 
complex mixture. The first step in a multidimensional separation is fractionation 
into simpler mixtures. These fractions are then chromatographically separated by 
reverse phase HPLC that allows maximum detection by the mass spectrometer. The 
first dimension fractionation methods  include, strong cation-exchange (SCX), 
strong anion exchange (SAX), reverse phase (RP), size exclusion chromatography 
(SEC), or  hydrophilic interaction chromatography (HILIC).
22
 Along with HPLC, 
sample fractionation techniques, and bioinformatics, mass spectrometry provides 
unbiased analyses of components in complex mixtures within a short time frame.   
In addition to HPLC and 2DE as a fractionation method for proteins, 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), is a 
popular method to fractionate proteins based on their molecular weight. The 
biggest limitation of SDS- PAGE as a fractionation technique is the recovery of 
protein from the gel.  An alternative, to extracting proteins from a gel, is Gel-Eluted 
Liquid Fraction Entrapment Electrophoresis (GELFrEE). This is molecular weight-
based separation involves continuous elution SDS-PAGE in a tube format, in which 
proteins are constantly eluted from the gel column and collected in the solution 
phase (i.e., free of the gel), providing broad mass range fractionation with good 
resolution, reproducibility, and recovery.
23
 Appropriate combinations of available 





The mass spectrometer is made up of three major components: the 
ionization source, the mass analyzer, and the detector. The sample of interest is 
ionized and then desorbed into the gas phase within the ionization source.
24
  The 
two most common methods to ionize biological molecules prior to the entrance into 
the analyzer region of the mass spectrometer are matrix-assisted laser desorption 
ionization (MALDI) and electrospray ionization (ESI). In 1989, John Fenn 
introduced a soft ionization technique, ESI, to ionize intact chemical species 
(proteins) by multiple charging.
25, 26
 The ionization is soft because very little 
residual energy is retained by the analyte, and generally no fragmentation occurs 
upon ionization.  In addition, weak noncovalent interactions can be preserved in the 
gas phase.
25, 27
  Because of the multiple charging, the m/z values of the resulting 
ions become lower and fall in the mass ranges of all common mass analyzers.  Thus 
ESI became very useful in the production of gas-phase ions from large biologically 
important macromolecules like proteins and nucleic acids, and their subsequent 
mass spectrometric analysis of structural characterization as well as their rapid 




The molecular mass of macromolecules can be calculated using the 
following formula: 




In the relationship above, M is the neutral mass of the macromolecule, m’ 
measured mass to charge ratio of the molecule, n is the number of charges and H is 
the mass of a proton.
1
  The number of charges on the protein molecule will depend 
on the molecular weight of the protein and the number of accessible basic sites (e.g. 
arginine, histidine and lysine).  Proteins exhibit different charge state distribution 
profiles in their ESI-mass spectra.
25
 
The mechanism by which ESI works is not completely understood. ESI 
requires the sample of interest to be in solution so that it may flow into the 
ionization source region of the mass spectrometer.
24
 The solution must be a 
conducting solution. The ionization occurs in three different processes: droplet 
formation, droplet shrinkage, and desorption of gaseous ions. The sample is ionized 
by applying high voltage through the stainless steel needle through which the 
sample flows.
24
 At the onset of the electrospray process, the electrostatic force on 
the liquid leads to the partial separation of charges. In positive-ion mode, cations 
concentrate at the tip of the metal capillary and tend to migrate towards the counter 
electrode. The migration of the accumulated positive ions towards the counter 
electrode is counterbalanced by surface tension of the liquid, giving rise to a Taylor 
cone at the tip of the capillary.
1
 As the sample exits the spray tip, the solution 
produces submicrometer-sized droplets containing both the conducting solute and 
analyte ions. The droplets are subsequently desolvated into gaseous ions and 








 Desorption is achieved by evaporation of the solvent by passing the 




Figure 2: Schematic representation of electrospray ionization.
25
 
Nano electrospray (nano-ES) is a miniaturized version of standard ESI and 
is desigened to operate at submicroliter flow rates.
30
 There are several practical 
differences in the operation of the two modes. Nano-ES utlizes a smaller spraying 
tip aperture, the stable spray is obtained at lower voltages, and the droplets 
produced are about 200 nm in diameter. The rate of desorption of  ions from small 
droplets and the mass molar sensitivity of ESI is inversely proportional to the 
flowrate. The nano-ES spray disperses the liquid purely by electrostatic means, and 
no assistance via the sheath flow gas is used.  Thus, it is a very stable source, which 
can spray a variety of buffers in both positive and negative mode.  The stability of 
the spray helps in measuring protein masses accurately.
30
  Nano-ES provides 







The LTQ-Orbitrap  
 
A mass analyzer separates the ionic species based on their mass-to-charge 
ratios. The different analyzers have benefits and deficiencies in protein mass 
spectrometry. Four types of mass analyzers used widely in the field are linear ion 
traps (LTQ), time-of-flight (TOF), Orbitrap, and the Fourier-transform ion 
cyclotron resonance (FTICR).  The two Fourier transform based analyzers used for 
top-down proteomics are the Orbitrap and the FTICR. Historically top-down 
protein analysis has been successful with FTICR as a mass analyzer. This requires 
a super conducting magnet, which is expensive to acquire and to maintain. The 
LTQ-hybrid Orbitrap, also a Fourier transform based instrument, is a good 
alternative to the FTICR. The two mass analyzers predominantly used for the work 
in this thesis are the linear ion trap and the Orbitrap. The working principles of 
these mass analyzers are discussed in the sections following. 
 
Linear Ion Traps 
Wolfgang Paul introduced the ion trap often referred as the Paul trap in 
1969
31
, and his contribution to mass spectrometry was recognized by the award of 
the 1989 Nobel Prize.
32
  LTQ, also known as two-dimensional quadrupole ion traps 
are rapidly finding new applications in many areas of mass spectrometry. 
Instruments such as TOF, FT-ICR, and Orbitrap have been coupled with the LTQ. 






 feature of an LTQ, with the mass accuracy and resolution of the FT or 
TOF based mass analyzers.
33
  Ion traps function based on oscillating electric and 
radio frequency (rf) potentials applied in three dimensions to maintain ion 
populations in regions of high stability.
34
 
Helium is used as a dampening gas inside the ion trap, due to its ability to 
energetically cool the ions without fragmenting them. When the ions enter the mass 
spectrometer they collide with the helium gas. This helps to slow the ions so that 
they can be trapped in the mass analyzer by the rf field. The true power of the ion-
trap analyzer is its ability to isolate and fragment peptide ions (MS/MS) from 
complex mixtures, such as those found in many proteomic analyses. To perform 
MS/MS analysis, specific ions are selected and the trapping voltages are adjusted to 
eject all other ions from the trap. The trapped ions undergo collision with helium 
gas, causing them to fragment. These fragments are then trapped and are scanned  





The Orbitrap mass analyzer was invented by Alexender Makarov and is an 
alternative to traditional superconducting magnet based FTMS systems for high 
resolution analysis. It is an ion trap with an oblong shape consisting of an outer 
barrel like electrode and a central spindle like electrode along the axis.
35
 The ions 
are injected orthogonally to the central electrode and are attracted to an increasing 
voltage on this central electrode. The outer electrodes oscillate polarity, causing the 












All ions in the Orbitrap have exactly the same amplitude, although ion 
packets of different m/z have a given oscillation at frequencies, which can be 
calculated using: 
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Where   the frequency of ion oscillation, m/z is is the mass to charge ratio and k is 
field curvature 
The outer electrode is split in half, allowing the ion image current due to the 
axial motion to be collected. The current is amplified from each half of the outer 
electrode and undergoes analog-to-digital conversion before processing, and image 


















   
 
For a given acquisition time the resolving power of the Orbitrap mass 
analyzer diminishes as the square root of m/z.  In addition, as the cross section of 
the background gas increases, the resolving power decreases with increasing mass. 
Collisions with the background gas can lead to fragmentation of ions, loss of ions, 
or ejection of ions from the trap. The Orbitrap mass analyzer produces spectra with 
mass accuracies in the range of 2–5 ppm. The main reason for a mass error in the 
Orbitrap for heavier proteins is the low signal to noise (S/N) of the precursor and 
product ions. Thus, as the S/N ratio increases, the accuracy of mass measurement 
improves.
38
 The hybrid LTQ-Orbitrap has two mass analyzers. The Orbitrap 
achieves higher resolution and mass accuracy which is important for the analysis of 
intact proteins. Whereas, the ion trap allows the isolation and fragmentation of ions 
of interest.  
 
Fragmentation of Intact Proteins 
 
Fragmentation plays an important role in identification of proteoforms and 
post-translational modification of proteins in complex mixtures.  It is important to 
optimize fragmentation conditions, as well as choose the suitable fragmentation 
method for a given analysis.  The full MS scan detects the m/z values of precursor 




from the dissociation of multiply charged protein ions and typically comprise ions 
with charges ranging from unity up to the charge of the precursor ion.
39
  High mass 
accuracy of both the precursor and product ion fragmentation patterns is very useful 
for protein and peptide identification using bioinformatic analysis.
40
 
Collisionally Induced Dissociation 
A common technique used to activate peptides and proteins is collisionally 
induced dissociation (CID). Peptide or protein molecular ions in the gas phase are 
collide with an inert gas, e.g. helium and nitrogen, in the collision cell.
41
 Collision 
with neutral gas atoms, leads to conversion of the kinetic energy of the ions into 
internal vibrational energy. As the vibrational energy exceeds a certain threshold, 
covalent peptide bonds break. The energy is randomly distributed between bonds 
and the weakest peptides bonds break.
42
 Typically, the preferred sites of cleavage in 
gas phase peptide ions are the amide bonds of the peptide bond. In this type of 
fragmentation, the amide bond of the peptide backbone will fragment to produce a 
series of b and y-type ions as shown in Figure 4. Due to the nature of CID, the 
fragmentation of large peptides is likely to be incomplete, and information on labile 
chemical modification on the protein is normally undetectable.
43
   
Electron Transfer Dissociation  
Electron transfer dissociation (ETD) is a new method to fragment peptide 
and proteins that complements the data obtained from CID.  It is suitable for 
fragmentation of larger molecular ions and is less destructive of modifications on 
peptides or proteins.
44




radical anion to a protonated peptide bond.  This transfer induces fragmentation of 
the peptide backbone, causing cleavage of the Cα-N bond generating series of c- 
and z- ions, and PTM linkages are not broken.
45
  The fragmentation patterns are 
shown in Figure 4. 
High Energy Collision Dissociation  
High energy collision dissociation (HCD) can also be performed on the 
LTQ-Orbitrap. HCD  employs higher energy dissociations than those used in ion 
trap CID, enabling a wider range of fragmentation pathways.
46
 The fragment 
pattern for HCD is due to the higher energy and the shorter activation time when 
compared to CID. Both b-ions and y-ions are observed in CID, whereas higher 
energy levels with HCD lead to more y-ions than b-ions. The b-ions may fragment 
further to a-ions or smaller pieces.
42
 Compared with traditional ion trap-based 
collision-induced dissociation, HCD fragmentation with the Orbitrap provides 
increased ion fragments and results in higher quality MS/MS spectra of proteins.   
 
Figure 4: Fragmentation pattern of protein backbone showing series of a- and x- 








One of the major bottlenecks of top-down proteomics is the limited number 
of bioinformatics tools for top-down data management and interpretation. Tandem 
mass spectra of proteins can be difficult to interpret because of the number of ions, 
the charge states of these different ions and the possible interferences. ProSightPC 
2.0 (Thermofisher scientific, San Jose, CA)  is the search program that is widely 
used in the high mass accuracy top-down approach to match protein fragment ions 
against the database of protein sequences.
47
  First, the program uses the algorithm 
THRASH
47
 or Xtract to deconvolute the multiply charged precursor fragment ions 
so that each protein, and each fragment, has only one mass.  Using a given mass 
tolerance it analyzes the data from a chromatographic time scale. The program then 
seeks as match to a theoretical protein based on matching the fragment masses 
within the assigned tolerance.  ProSightPC assigns an expect value (E–value) to 
every matched protein, which measures how likely the match is, compared to a 
match to a random protein. The expectation value (E-value) is calculated based on 




         
A lower E-value gives higher confidence to the match of the observed and 
theoretical data. Additionally, ProSightPC has a tool that allows the user to check 
for a previously unknown modification after the search has been completed.
48




to all the features described above, ProSightPC 2.0 is widely used for the analysis 
in this work. 
Intact protein analysis workflow 
 A general intact protein analysis workflow is shown in Figure 5. A complex 
mixture of interest is usually fractionated using chromatographic methods. 
Following elution the proteins are ionized, typically using ESI ionization method. 
The MS1 scan or the precursor ion scan of the ionized proteins are recorded using 
high resolution mass analyzers. The precursor ion of interested is isolated and 
fragmented using CID, ETD or HCD fragmentation methods. The fragment ion 
scan, or the MS2, of the resulting fragments are recorded using a high resolution 
mass analyzer. The data is searched against a customized database and specialized 
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The goal of this thesis is to develop an effective work flow for analysis of 
intact proteins using an LC-LTQ-Orbitrap, including front end chromatographic 
separation and the high resolution analysis of both precursor ions and product ions 
that is required to assign charge states and thus interpret the spectra.  We have used 
standard proteins to optimize HPLC conditions and to compare three methods for 
ion activation and dissociation. The optimized method is extended to analyze low 
mass proteins in cancer cell MCF7 cytosol and E. coli lysate.  Molecular weight 
cut-off filters, basic reversed- phase high performance liquid chromatograph and 
tubular electrophoresis are evaluated as fractionation methods for sample 
preparation in these model complex mixtures. Finally, this work flow is applied to 
identify and characterize proteins from EVs shed by murine MDSC cells. The top-
down analysis of intact proteins from these EVs was utilized to identify low mass 




















Despite the availability of high performance mass spectrometers, methods 
for intact protein separation, identification of intact proteins and their proteoforms 
are yet underdeveloped and remain a challenge for solution-based proteomics 
platforms. A variety of fractionation techniques including isoelectric focusing, 
capillary electric focusing, 2DE, GELFrEE, reverse phase liquid chromatography 
(RPLC), SCX, have been utilized in fractionating intact proteins prior to MS 
analysis. While gel based separations were widely adapted in top-down proteomics, 
its limitations for extraction of proteins from the gel makes in solution-based 
fractionation a suitable alternative. HPLC coupled with ESI-MS is an essential tool 
in proteomics, due to its compatibility with the electrospray ionization technique.  
To reduce the complexity of a sample it is important to fractionate protein mixtures 
prior to liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis.  
The evolution of both column material and packing designs contribute to strong 
efforts in increasing the improvement of fractionation of intact proteins, mainly in 
order to miniaturize the process and avoid sample loss.  Progress has been made in 
column chromatography with both porous and non-porous packing materials.   
The application of any single fractionation method provides insufficient 




dimensional LC-MS/MS analysis is typically limited, and fractionating protein 
samples prior to analysis is important for increasing both the analytical dynamic 
range and proteome coverage. Two-dimensional liquid chromatography (2D LC) 
provides higher peak capacity and dynamic range for complex mixtures. In 
addition, it enhances the probability of identifying lower abundance proteins whose 
ions may be suppressed in complex samples. Although 2D LC significantly 
increases the peak capacity of the chromatographic conditions, identical proteins 
are often present in multiple fractions. The effectiveness of a 2D LC separation 
depends on the compatibility of the two separations, the separation efficiency and 
the separation orthogonality. Since strong cation exchanged (SCX) employs a 
different separation mechanism and provides good orthogonality to RPLC, it has 
been widely used as the first dimension for 2D LC-MS/MS. SCX as choice of 
fractionation methods in the first dimension has its limitations, including reduced 
sample recovery and sample losses due to sample desalting prior to second 
dimension analysis. Thus basic reversed-acidic reversed phase high performance 
liquid chromatography (bRP-aRP-LC)
49
 has gained popularity as method that 
provides more effective separation than SCX. It generates cleaner fractions and that 
reduces both sample processing steps and sample loss. In this fractionation 
workflow, the first dimension is an offline fractionation with a solvent system at 
pH 10.0, and the second dimension is an online LC-MS/MS analysis with a solvent 
system at pH 2.0.    
The objective of this experiment is to evaluate various reverse phase 




separation of complex mixtures. The multidimensional chromatographic technique 
bRP-aRP-LC was evaluated using E. coli lysate as a model complex mixture to 
improve the resolving power for separation of intact proteins, and to increase the 
number of protein and proteoform identifications.  
Evaluation of Chromatographic Columns 
Material and Methods 
Sample preparation and HPLC method: Ten micromolar solution of 
lysozyme, cytochrome c, myoglobin and ribonuclease A (Sigma Aldrich, St. Louis, 
MO) was prepared in solvent A (97.4% water, 2.5% acetonitrile (ACN) and 0.1% 
formic acid). Reversed phase chromatography with 50 µL protein standard mix was 
performed using a Thermo Accela LC (San Jose, CA) or Shimadzu Prominence LC 
(Columbia, MD) pump with the chromatographic columns, at flow rates of 300 
nL/min to 50 µL/min depending on the inner diameter of the column. A gradient 
elution was employed and the concentration of solvent B (97.5% acetonitrile, 2.4% 
water, 0.1% formic acid) was increased linearly from zero to 85% in 60 minutes. 
The chromatograms were acquired with a SPD-10A UV (Shimadzu, Columbia, 
MD) spectrometer at a wavelength of 214 nm. 
Results and Discussion 
The six acid reversed phase columns that were evaluated were Kinetex core 
shell column (Phenomenex, Toraance, CA), C3 capillary column (Agilent, 
Wilmington, De), Xbridge (Waters, Milford, MA), Grace C18 (Vydac, Deerfield, 




column (Dionex, Bannockburn, IL). The column chemistry, diameter and particle 
size for the six columns are indicated in Table 1.  All columns were evaluated using 
standard protein mix. The Kinetex core shell column and the Agilent Zorbax 
columns were evaluated for the second dimension in the bRP-aRP LC. The Waters 
















C18 2.1 100 150x2.1 27,300 50 µL/min 
Agilent 
Zorbax 
C3 5 300 150x0.1 17,700 300 nL/min 
Waters 
Xbridge 
C18 3.5 300 250x4.6 18,300 300 µL/min 
Grace Vydac C4 5 300 250x1.0 3,600 50 µL/min 
Michrom 
PLRP-S 




Phenyl NA NA 50X1.0 2,200 100 µL/min 
 





The number of theoretical plates for each column was calculated based on the 
retention time and peak width for cytochrome c for each run.  From the columns 
evaluated, the number of theoretical plates observed was highest in the Kinetex 
core shell, Agilent C3 and the Xbridge, respectively. Consequently, these three 





Figure 6: Chromatograms for reversed phase separation of four protein standard 
mix using, using  (A) Kinetex core shell column, (B) Agilent C3 column and  (C)  
Xbridge column Standards used were: 1. Lysozyme; 2. Ribonuclease A; 3. 


















 The advantage of the Kinetex core shell and the Agilent C3 column were 
that the particles were not fully porous resulting in a reduced diffusion path and 
thus maximizing separation efficiency. The porous packing material of these 
columns also results in lower back pressure on the HPLC system. Thus the amount 
of intact protein that can be loaded on these columns is 2 to 3 fold times higher 
compared to columns packed with non-porous particles. The Agilent C3 column 
has a smaller inner diameter; therefore it is a nanoflow column and it requires less 
starting material for intact protein analysis. Due to the lower flow rate of 300 
nL/min, the C3 column is compatible with the Nano ES source, therefore, it 
provides a higher sensitivity and dynamic range for the analysis of intact proteins. 
In addition, the Xbridge column provided a higher number of theoretical plates, 
since it is 250 mm in length. While longer columns increase the peak capacity for 
the analysis of complex mixtures, the back pressure on the system is also higher, 
thus the amount of sample that can be loaded onto the Xbridge column is much 
lower than Kinetex core shell column. The biggest advantage of the Xbridge 
column was that the particles were stable at extreme solvent pH and thus could be 
employed with various solvent systems. In the literature, PLRP-S and Monolithic 
columns have showed reduced chromatographic peak widths, fast mass transfer, 
low back pressure and high loadability of sample.
50-53
  However in our hands, we 
found that the performance of these columns, based on the number of theoretical 
plates, separation and peak width, was lower for intact proteins for the lower 




chromatographic columns utilized for the work in this thesis are the Kinetex core 
shell column, Aglient C3 column and the Waters Xbridge column. 
 
Evaluation of bRP-aRP LC-MS/MS analysis of E. coli lysate 
Material and Methods 
E. coli Lysate:  Forty milligrams (mg) of lyophilized K12 strain E. coli 
(Sigma Aldrich, St. Louis, MO) was suspended in 500 µl of 10% formic acid and 
vortexed. The sample was centrifuged at 14,000 rotation per minute (RPM) for 15 
minutes. Proteins were precipitated with cold acetone for 30 minutes and 
centrifuged at 10,000 g for 20 minutes. The resultant pellet was re-suspended in 
500 µL of Solvent A (97.5% water, 2.4% ACN, 0.1% formic acid) and filtered 
through a 0.22 µM filter.  The protein concentration of the sample was determined 
using RC/DC assay (BioRad). 
1D-LC analysis: Seventy-five micrograms of E. coli lysate was injected 
onto a Kinetex core shell column with a flow rate of 100 µL/min. Reversed phase 
chromatography was carried out on a Shimadzu Prominence LC system and 
Autosampler, with a linear gradient of increasing concentration of Solvent B 
(97.5% ACN, 2.4% water and 0.1% formic acid) from 10% to 85% over 110 
minutes.  
bRP-LC analysis: Two hundred micrograms (µg) of E. coli lysate was 




used for the first dimension were: solvent A composed of 50 mM ammonium 
hydroxide in water and solvent B composed 50 mM ammonium hydroxide in water 
and ACN (2:8).
54
 Reversed phase chromatography was carried out on a Thermo 
Accela LC system with a step gradient of increasing concentration of solvent B 
from 10% to 90% over 60 minutes. The samples were detected with a SPD-10A 
UV spectrometer at 214 nm. A total of five fractions were collected, lyophilized 
and re-suspended in solvent A (97.5% water, 2.4% ACN, 0.1% formic acid) for the 
second dimension. Each fraction was injected onto a Kinetex core shell column 
with a flow rate of 100 µL/min. Reversed phase chromatography was carried out on 
Shimadzu Prominence LC system and autosampler with a linear gradient of 
increasing concentration of solvent B (97.5% ACN, 2.4% water and 0.1% formic 
acid) from 10% to 85% over 110 minutes.  
MS analysis for 1D and aRP LC samples: A LC was connected in line 
with an LTQ-Orbitrap-XL (ThermoFisher, San Jose, CA) and the precursor scans 
were recorded in the Orbitrap at a resolution of 60,000 at 400 m/z.  The four most 
abundant signals for each precursor scan were subjected to CID fragmentation with 
activation energy at nominal 35. MS/MS spectra were recorded in the Orbitrap at a 
resolution of 30,000 at 400 m/z.  Data dependent analysis was set to isolate 
precursor ions with unassigned charges and charges greater than +4. The isolation 
width for the precursor ions was set to 10 Da. The automatic gain control (AGC) 
targets were set to 1E6 for precursor scan and 1E5 for the four MS/MS scans. 
Bioinformatics:  Database searches were performed using ProSightPC 
2.0
55




consisting of proteins with molecular weight less than 30KDa. The THRASH
56
 
algorithm was used to decharge both the precursor and the fragment ions.  
Precursor mass tolerance was set to 250 Da and the fragment mass tolerance was 
set to 15 ppm. The ΔM mode on ProSightPC PC 2.0 was used to localize any mass 
shifts at the N- or C- terminus of the protein. Post-translational modifications and 
mass shifts were investigated manually using Sequence Gazer available in the 
software. The proteins identified were automatically assigned an E-value. 
Identifications with E-values lower than 10E-4 were considered as strong 
identifications.  
Results and Discussion 
Fractionation of intact proteins in complex mixtures plays an important role 
in increasing the number of proteoforms and proteins identified in a given analysis. 
Fractionation using multidimensional LC-MS/MS analysis enables the 
identification of  proteins with lower abundances, proteins that may co-elute and 
proteins whose signal may be suppressed in a 1D- LC-MS/MS analysis. The step 
gradient employed and the UV chromatogram for the first dimension fractionation 
are shown in Figure 7.  
It was important to employ the step gradient in the first dimension, so that 
we observe a valley in the chromatogram at a fixed time interval. Five fractions 
were collected, each at the valley in the chromatogram as shown in Figure 7. This 
ensures that a group of proteins with different hydrophobicity can be collected in 
each different fraction and it aids in minimizing overlap between fractions. In this 




MS/MS analysis, while 38 unique proteins were identified from the five fractions 





Figure 7: (A) Step gradient employed for the first dimension (B) Chromatogram of 







































Three of the proteins identified in 1D LC-MS/MS were not observed in the 
bRP-aRP-LC-MS/MS work flow. The mass ranges of the proteins identified in the 
bRP-aRP LC-MS/MS were from 4.9 KDa to 13.6 KDa and the combined number 
of proteins identified doubled compared to 1D LC-MS/MS analysis.  A list of the 
proteins identified from both the analyses is provided in Appendix Tables 1 and 2. 
Figure 8 and 9 shows the mass ranges of the proteins identified and the number of 
unique proteins identified in each fraction. There were 22 proteins identified 
between mass ranges of 7000 Da to 10,000 Da whereas, 8 proteins were identified 
between 10,000 Da and 13,000 Da.   
 
 






























The number of unique proteins identified in fractions 5, 4 and 3 were 20, 2, 
and 6 proteins, respectively.  While, there was some overlap between fractions, 
80% of the proteins identified were unique to a given fraction. There were no 
proteins identified in fractions 1 and 2, and a majority of the proteins were 
identified in fraction 5. 
 
 
Figure 9:  Distinct proteins identified in each fraction in bRP-aRP LC-MS/MS 
analysis. 
The heaviest protein identified was in bRP fraction 5 and eluted at 61.42 
minutes in the aRP gradient; a precursor ion of 1246.12 with a charge state of +11 
was isolated and fragmented. The protein was identified with a reliable E value of 
9.11E-06 and was identified as hypothetical protein ECB_03458 with an intact 
mass of 13688.3 Da which was 0.05 Da less than the theoretical mass.  The 
precursor and product ion scans, the decharged product ions and the fragments 
matched are shown in Figure 10.  
Fraction 5  1 
Fraction  4  1 







Figure 10: (A) Precursor ions scan at retention time 61.42 in fraction 5, (B) Product 
ions from m/z=1246.12 with charge state +11, (C) Decharged  product ion scan; 










Post translational modifications were observed on 8 proteins and localized 
on 7 for 1D LC-MS/MS analysis. While, there were modifications observed on 9 
proteins and localized on 8 for bRP-aRP LCMS/MS analysis of the E. coli lysate. 
Modifications on the proteins were manually investigated using the Sequence 
Gazer tool in ProSightPC 2.0 for proteins where a mass difference was observed 
between the theoretical and experimental intact masses. The number of matched 
fragments increases when a PTM is localized on a protein, which lowers the E-
value of the protein, and increases the confidence of the identification of the 
protein. 50S Ribosomal protein is identified in fraction 5 of the bRP-aRP LC 
analysis. The precursor ion spectrum at 19.73 minutes and the product ion spectrum 
for ions of m/z 894.52 with a charge state of +7 are shown in Figure 11. The mass 
observed for the protein was 6250.57 Da which 13.99 Da is heavier than the 
theoretical mass of the protein. The localization of a post translational modification 
on 50S ribosomal protein L33 is shown in Figure 12. The mass difference between 
the observed and experimental intact mass was 13.98 Da. In addition, since only 
the 11 y-ions were matched, the PTM on the protein should theoretically be on the 
N-terminus. Thus, when a mass shift of 13.98 Da or methylation was applied to the 
alanine residue on the N-terminus, the number of fragments matching the protein 
increased from 11 fragments to 25 fragments. Also, the E-Value of the protein 






Figure 11: (A) Precursor ion spectrum at retention time 19.73 minutes from fraction 
5 of bRP-aRP LC analysis of 50S ribosomal protein L33 (B) Product ions from m/z 












Figure 12: Protein sequence of 50S ribosomal protein L33 (A) based on 11 y-ions 
observed with E value of 2.06E-18 (B) based on 14 b-ions and 11 y-ions with E 
value of 8.86E-49 when methylation is assigned first alanine amino acid residue.  
 
DNA-binding transcriptional regulator, alpha subunit was identified in 
fraction 5 from the bRP-aRP LC analysis.  The precursor ion spectrum at 50.55 
minutes and the product ion spectrum for ions of m/z 737.76 with a charge state of 
+13 and the fragmentation observed are shown in Figure 13. The protein was 
identified with a strong E-value of 4.27E-19 and the observed mass of the protein 








Figure 13: (A) Precursor ions scan at retention time 50.55 in fraction 5, (B) Product 
ions from m/z 737.76 with charge state +13, (C) Decharged product ion scan; (D) 
protein sequence and observed 8 b-ions and 11 y-ions from DNA-binding 









Three experimental replicates of bRP-HPLC-MS/MS analysis were 
performed to evaluate the reproducibility of the method. The number of proteins 
identified in the three experiments was 38, 36, and 32, respectively. While most of 
the proteins identified between the analyses were the same, there were seven 
proteins identified that were not detected in all three experiments. The reason for 
the difference in identification of proteins is the complexity of the sample. During 
the LC-MS/MS analysis in the second dimension, at any given time there is more 
than one protein eluting from the column. Thus, the mass spectrometer could be 
isolating and fragmenting different precursor ions for a given fraction between 














































Conclusion   
 Optimized front end fractionation is essential to increase the number of 
identifications and proteoforms of intact protein from complex mixtures.  From the 
columns evaluated, the Kinetex core shell column, Agilent C3 and the Waters 
Xbridge column were employed for the 1D-LC-MS/MS and bRP-aRP-LC MS/MS 
analysis. These columns provided a higher number of theoretical plates and were 
compatible with the HPLC system, as well as, solvents used in the analysis. In the 
bRP-aRP LC-MS/MS analysis, the step gradient in the first dimension was 
important so as to observe valleys at a fixed time interval in the chromatogram. 
This led in reducing the overlap of proteins identified between fractions. The 
number of identifications using bRP-aRP LC-MS/MS analysis increases more than 
two fold. Therefore, there is a need for offline fractionation of intact proteins in 















The use of tandem mass spectrometry is important in proteomics for protein 
identification and characterization. In tandem mass spectrometry the charged ions 
within a specific mass to charge ratio (m/z) are isolated, subjected to fragmentation 
and the mass to charge ratio of the resulting fragment ions recorded. Optimized 
fragmentation of proteins is a key step in top-down approaches using mass 
spectrometry based proteomics. Employing a fragmentation method that produces a 
homologous series of fragment ions is important for confident protein 
identifications in complex mixtures. The most common fragmentation techniques 
for intact proteins are via collisions of an inert-gas or electron-based fragmentation. 
The three type of fragmentation available on LTQ-Orbitrap XL are low energy 
collisionally induced dissociation (CID), high energy collision dissociation (HCD) 
and electron transfer dissociation (ETD). The basic principle of all three 
fragmentation methods are discussed in Chapter 1.  
The Orbitrap provides isotopic resolution of the analyte, which allows the 
charge state of ions to be determined. The charge state of a protein can be 
calculated using the following formula:  
   







In addition to fragmentation methods, the number of averaged scans and the 
resolution also play an important role in assigning the fragment ions of the proteins 
being analyzed.   In the relationship above the charge state is the inverse of the 
mass to charge difference between two isotopic peaks, since the mass difference 
between two 
13
C peaks is 1 Da 
 
 
Figure 15: Expanded view of precursor ion spectrum from an E. coli LC-MS/MS 
analysis, showing the mass difference between isotopic peaks. 
 
As the mass of the protein increases, the number of charge states usually 
increases and the mass difference between the isotopic peaks decreases, which is 




The objective of the experiments presented in this chapter was to optimize 
the parameters employed to obtain product ion spectra; specifically, the 
fragmentation conditions, number of averaged scans and resolution for different 
mass range of the proteins desired to be analyzed.  Intact ubiquitin (8.5 KDa), 
cytochrome c (12.7 KDa), myoglobin (16.8 KDa) were employed to evaluate the 
reaction time for ETD and activation energies for CID and HCD fragmentation 
methods. Fragmentation conditions were also evaluated for intact proteins from the 
cytosol of MCF-7 cancer cells on a LC-MS/MS timescale.  The effect of averaged 
scans for precursor ions was evaluated by infusing myoglobin and by the LC-
MS/MS analysis of cytosolic proteins from MCF-7 cancer cells.  
.  
Evaluation of Fragmentation Conditions for Intact Proteins 
 
Materials and Methods 
Sample preparation and MS analysis:  One micromolar solution each of 
ubiquitin, cytochrome c, myoglobin (Sigma Aldrich, St. Louis, MO) was prepared 
in 50% ACN, 49.9% water and 0.1% formic acid. Each protein solution was 
infused individually into the LTQ-Orbtrap XL using a syringe that was set at a flow 
rate of 1 µL/min. The precursor ion scan was acquired at a resolution of 60,000 at 
400 m/z and the fragment ion scans were automatically acquired at a resolution of 
15,000 at 400 m/z for the top three most abundant ions. Data dependent analysis 
was set to isolate precursor ions with unassigned charges and charges greater than 




were set to 1E6 for precursor scans and 1E5 for the MS/MS scans. Dynamic 
exclusion was employed with a repeat count of 1, repeat duration of 30 seconds and 
exclusion duration of 30 seconds.  The normalized collision energy was evaluated 
for CID and HCD for all three proteins. The energy was varied from 15 to 30 at 
increment of 5. ETD fragmentation was evaluated for the three proteins by varying 
the reaction time from 5 milliseconds (ms) to 25 ms at increments of 5 ms. The 
instrument was set to collect the spectrum for each repetitively for 2 minutes 
Bioinformatics:  Database search was performed using ProSightPC 2.0
55
 
against a custom UniProt database consisting of the sequences from the three 
proteins. The THRASH
56
 algorithm was used to deconvolute both the precursor 
and the fragment ions.  Precursor mass tolerance was set to 250 Da and the 
fragment mass tolerance was set to 15 ppm. The proteins identified were 
automatically assigned an E-value, identifications with E-value lower than 10E-4 
were considered as a strong identification 
Results and Discussion 
Ubiquitin, cytochrome c and myoglobin were chosen for the evaluation of 
the fragmentation conditions since all three weigh less than 30 KDa. The number of 
fragments from the three proteins for the different conditions from the three 
fragmentation methods was identified using ProSightPC.  
The results presented in Figures 16, 17 and 18 indicate the number of 
fragments identified using ProSightPC from ubiquitin, cytochrome c and 




fragments identified for all three proteins using CID and HCD methods decrease at 
higher activation energy. The molecular weight did not play an important role in 
CID fragmentation. In the case of HCD at higher activation energy internal 
fragmentation was observed, which the software could not match. It was observed 
that as the molecular weight of the protein increased the number of fragments 
matched using HCD decreased. In the case of the myoglobin due to extensive 
internal fragmentation, no fragments were identified at even low activation energy 
using HCD.  
For ETD, results show that the charge state and the molecular weight of the 
protein play an important role in producing fragment ions. For ubiquitin, the 
reaction time of 20 ms yielded the highest number of matched fragments. Whereas, 
a reaction time of 5 ms yielded the higher number of matched fragments for 
myoglobin.  In both cases it was observed that the number of fragments identified 
decreases with increasing reaction time for the analysis. The fragmentation using 
ETD is protein dependent. Thus there were no confident fragments identified from  
the ETD analysis of cytochrome c. Extensive fragmentation was observed from 
lower charge states precursor ions for CID and HCD compared to ETD for all three 











Figure 16: (A) Number of Fragments from CID for ubiquitin with varying 
normalized collision energy, (B) Number of fragments from HCD for ubiquitin 
with varying normalized collision energy, (C) Number of fragments from ETD for 

















































































































Figure 17: (A) Number of Fragments from CID for cytochrome c with varying 
normalized collision energy (B) Number of fragments from HCD for cytochrome c 






































































Figure 18: (A) Number of Fragments from CID for myoglobin with varying 
normalized collision energy, (B) Number of fragments from ETD for myoglobin 

































































Effect of Averaged Scans for Precursor Ions 
Materials and Methods 
Sample preparation and MS analysis of myoglobin: One micromolar 
solution of myoglobin was prepared in 50% ACN, 49.9% water and 0.1% formic 
acid. The solution was directly infused into the LTQ-Orbtrap XL at using an ESI 
source and a syringe that was set at a flow rate of 1 µL/min. The precursor ion 
scans were acquired at resolutions of 15K, 30K 60K and 100K at 400 m/z and the 
number of scans averaged for each resolution setting was 1, 3, 5 and 10. The 
instrument was set to collect the spectra for each for 0.5 minutes. 
Sample preparation of cytosolic proteins from MCF-7 cells:  MCF-7 
breast cancer cells were grown to confluence in Improved Minimal Essential 
Medium (ATCC, Manassas, VA) supplemented with 1% penicillin and 10% fetal 
bovine serum (Sigma Aldrich, St. Louis, MO) with 5% carbon dioxide and at 37 
°C. The cells were detached by adding 5 mL of trypsin and incubating the flask at 
37 °C for 5 minutes. The cells were washed two times with 5 volumes of phosphate 
buffered saline (PBS) and once with 10 volumes of 10 mM NaCl. The cells were 
collected by centrifugation at 500g for 10 minutes. Cytosolic proteins from the cells 
were extracted using  digitonin buffer (10 mM PIPES, 0.015% digitonin, 300 mM 
sucrose, 100 mM NaCl, 3 mM MgCl2, 5 mM EDTA, and 1 mM protease inhibitor 
(PMSF), pH 6.8) at 4 °C on a shaker for 15 minutes. The cytosolic proteins were 
collected by centrifugation at 10,000 g for 10 minutes.
60
 The protein concentration 





61 and the pellet was re-suspended in 90% water, 
5% ACN and 5% formic acid. 
MS analysis LC analysis for cytosolic proteins:  Shimadzu Prominence 
nano LC system and autosampler was used for the LC analysis. Fifty micrograms 
of cytosolic proteins from MCF-7 cells was loaded onto a Zorbax (5 μm, 5 mm x 
0.3 mm) trap column (Agilent, Wilmington, De) and washed with Solvent A 
(97.5% Water, 2.5% ACN and 0.1% formic acid) for 10 minutes at 10 µL/min. The 
proteins were then fractionated using Agilent C3 (5 μm, 150 mm x 0.1 mm) column 
at a flow rate of 300 nL/min and a linear gradient of increasing concentration of 
Solvent B (97.5% ACN, 2.4% water and 0.1% formic acid) from 10% to 85% over 
90 minutes. The LC was connected in line with a LTQ-Orbitrap-XL and the 
precursor scans were recorded in the Orbitrap at a resolution of 60,000 at 400 m/z 
with either 1 or 5 averaged scans. The most abundant signal for each precursor scan 
were subjected to CID fragmentation with activation energy of 35, MS/MS spectra 
were recorded in the Orbitrap at a resolution of 60,000 at 400 m/z with 5 averaged 
scans.  Data dependent analysis was set to isolate precursor ions with unassigned 
charges and charges greater than +4. The isolation width for the precursor ions was 
set to 10 Da. The AGC targets were set to 1E6 for precursor scan and 1E5 for the 
four MS/MS scans. Dynamic exclusion was employed with a repeat count of 1, 
repeat duration of 15 seconds and exclusion duration of 30 seconds.   
Bioinformatics:  Database searching was performed using ProSightPC 
2.0
55
 against a custom UniProt human database consisting of the sequences of 
proteins with molecular weight less than 30 KDa. The THRASH
56




used to deconvolute both the precursor and the fragment ions.  Precursor mass 
tolerance was set to 2000 Da and the fragment mass tolerance was set to 15 ppm. 
The ΔM mode on ProSightPC 2.0 was used to localize any mass shifts at the N- or 
C- terminus of the protein. Post-translational modifications and mass shifts were 
investigated manually using Sequence Gazer available in the software. The proteins 
identified were automatically assigned an E-value, identifications with E-value 
lower than 10E-4 was considered as a strong identification. 
Results and Discussion 
 An intact protein ionized using ESI has multiple charges. These charges are 
calculated using the mass difference between the isotopic peaks as mentioned 
earlier in this chapter.  As the mass of the protein increases, the difference between 
the isotopic peaks decreases. This is one of the main reasons why the analysis of 
intact proteins require high resolution FTMS or TOF based instrument. It is 
observed that the resolution of the Orbitrap diminishes with an increase of mass of 
the protein, even if m/z is unchanged. This is due to the collision with background 
noise that leads to the fragmentation of ions and the formation of fragment ions.
36
 
Due to the reason mentioned above it important the precursor and fragments ions 





Figure 19: Zoomed in precursor ion scan of myoglobin at charge state of +17, 
showing the isotopic peaks at; (A) 15,000 resolution at m/z 400, (B) 30,000 
resolution at m/z 400, (C) 60,000 resolution at m/z 400, (D) 100,000 resolution at 
m/z 400.  
The precursor ion scan of the myoglobin was acquired by infusing the 
protein at various resolutions available on the LTQ-Orbitrap XL. In Figure 19, the 
ion at 998.15 with charge state +17 is evaluated for the for resolution settings. The 
isotopic peaks of the ions are well separated at higher resolution. Although, even at 
a resolution of the 100,000 at m/z 400 the charge state of this ion cannot be 
detected by a single scan. Thus, there is a need to average scans especially for 













Figure 20: Effect of averaged scan on ions from myoglobin with charge states +16 
and +17 for prescursor ion scans. (A) resolution of 15K at400 m/z, (B)  resolution 
of 30K at 400 m/z (C) resolution of 60K at 400 m/z, (D) resolution of 100K at 400 
































































































The effect of resolution by averaging scans for the precurosr ion is shown in 
Figure 20. It is observed that the resolution is increased by averaging scans for the 
precursor ion. In the case of resolution of 100,000, the resolution of the ion with 
charge state of +16 increases from 68,000 for one averaged scan to 72,000 for ten 
averaged scans. The reason being, by averaging scans the instrument acquires the 
transient for a longer time due to which  there is an increase in the resolution of the 
ion. In addition, the signal to noise  for the +16 ion at the same resolution increases 
two fold from 95 using one averaged scan to 192 using ten averaged scans.  
Even though it is experimentally evident that the averaged scan improves 
both the resolution and S/N to noise for ions from heavier proteins, it also increases 
the time taken by the instrument to acquire the scan.  Typically, a single scan at 
resolution 15,000 takes 0.25 seconds to acquire; whereas, its takes 0.5 second, 1 
second and 2 seconds to acquire a single scan at resolution of 30,000, 60,000 and 
100,000, respectively. Ten averaged scans at 100,000 resolution takes 
approximately 20 seconds to acquire by the Orbitrap. While this time scale would 
be feasible for an experiment where the protein is being directly infused, it would 
be difficult to average so many scans at a high resolution on an LC-MS/MS time 
scale. It is important to utilize high resolution and averaged scans for both the 
precursor ions and fragment ions, but it is also important to balance the duty cycle 
for LC-MS analysis. In the case of complex mixtures, typically there is more than 
one protein eluting at a given time. Therefore, if the duty cycle on the mass 




spectrometer.  As a compromise, a resolution of 60,000 and five averaged scans for 
both precursor and fragment ions was employed in most experiments.  
 
While the effects of averaged scans were analyzed by infusing proteins into 
the mass spectrometer, it was important to evaluate averaging the precursor ions 
scan for a complex mixture on a LC-MS/MS time scale. Cytosolic proteins from 
MCF-7 cancer cells were employed for this analysis. Two fifty-microgram samples 
were injected onto a C3 column in line with the LTQ-Orbitrap XL. The two 
experiments used the same LC gradient and MS fragmentation conditions. The first 
sample was analyzed using one precursor ion scan at resolution of 60,000 and the 
second with five averaged precursor scans at the same resolution.   
The total number of unique proteins identified with one averaged precursor 
ion scan is 14 proteins, while the number of unique proteins identified with five 
average precursor ion scan is 13. The list of proteins identified from the two 
analyses is listed in the Appendix Table 3 and 4. There were 11 proteins 
overlapping between the two samples. The mass range of proteins identified using 
one averaged precursor ion scan is 4.0 KDa-12 KDa, whereas the mass range of the 
proteins identified with five averaged scans is from 5.0 KDa to 22.7 KDa.  The 
percentage of proteins identified in the mass range of 9.0 KDa and 22.7 KDa is 
higher in the experiment where there are five averaged scans for the precursor ion. 








Figure 21: Percentage of proteins of different masses identified from MCF-7 







































The heavist protein in the analysis is identified a heat shock beta protein-1. 
The precursor and fragment ion spectra are shown in Figure 22 and 23. The 
precursor ion of 912.88 with charge state of +25 was selected for fragmentation 
The protein was identfied with a 7 y-ions, a mass of  22,678.61 Da and with an E-
value of 7.35E-05 . The theoretical mass of the protein is 22,768.5 Da. Thus, the 
mass difference between the theortical and observed mass was -89.89 Da. All the 
fragments identifed were only y-ions,  indicating that the PTM was on the  first 150 
residues of the protein. Thus, using Sequence Gazer in ProSightPC if the initial 
methionine is removed (-131.19 Da) and  the mass of an acetylation (+42.01 Da) is 
applied to theronine residue, the number of fragment ions matched go from 7 to 11 
ions with additional 4 b-ions matched. In addition, there is a small mass difference 
between the observed and theortical mass and the E-value is 4.3E-18 making it a 








Figure 22: (A) Precursor Ion spectrum at retention time 39.08 minutes from 
analysis with five averaged precursor ion scans, (B) Product ions from m/z 912.88 









Figure 23: (A) Protein sequence and fragments observed from heat shock beta-1 
protein identified by ProSightPC with an E-value of 7.35E-05 and mass difference 
of -89.89 Da compared to the theoretical mass, (B) PTMs localized and highlighted 







In the analysis with five averaged scans for the precursor ion scan, co-
elution of multiple proteins was observed  at a retention time of 25.50 minutes. The 
precursor ion spectrum obtained at  this retention time is shown in Figure 24A. The 
ion with 1332.61 and charge state of +9, was identified as prothymosin alpha. The 
observed mass for the protein was 11978.95, which is 217.05 Da less than the 
theortical mass of 12,196 Da. There were 18 y-ions that were matched using 
ProSightPC with a E-value of 9.43E-25. The mass difference corresponds to the 
truncation of the first two amino acid resides and matches the mass of  methionine 
(131.19) and serine (87.08). If this change is applied to the protein using Sequence 
Gazer in ProSightPC, the E-value of the protein drops to 1.13E-29 and an 
additional 6 b-ions are matched making this a very confident match. Similarly, in 
the following product ion scan the ion with 881.02 and charge state of +13 was 
selected for fragmentation, was identified as parathymosin with an observed mass 
of 11,434.23 Da and E-value of 4.07E-11. The theoretical mass of the protein is 
11,523.2 Da, which is 88.97 Da heavier than the theoretical mass. Using Sequence 
Gazer in ProSightPC, the PTM was localized in the first 40 residues by adding an 
acetylation to the serine (+42.01 Da) residue and removal of the initial methionine 
(-131.19 Da).  The E-value of the protein dropped to 7.18E-18 and 7 additional b-
ions were identified in addition to previously matched 3 y-ions.  Identification of 
co-eluting proteins is feasible when averaging scans for the precursor ion spectrum 








Figure 24: (A) Precursor Ion spectrum at retention time 25.50 minutes from 
analysis with five averaged precursor ion scans, (B) Decharged product ions from 
m/z 1332.61 with charge of +9, (C) Decharged product spectrum from m/z 881.02 










Figure 25: (A) Protein sequence and fragments observed for prothymosin alpha 
with a theoretical mass of 12,196 Da. PTMs localized and highlighted in green 
using Sequence Gazer in ProSightPC, (B) Protein sequence and fragments observed 
for parathymosin with a theoretical mass of 11,434.23 Da, PTMs localized and 






Comparsion of CID and ETD on an LC-MS/MS Time Scale for Complex 
Mixtures 
 
Material and Methods 
Sample preparation of cytosolic proteins from MCF-7 cells:  cytosolic 
proteins from MCF-7 cancer cells were prepared as described in the earlier section 
of this chapter  
LC analysis and MS analysis for cytosolic proteins:  A Shimadzu 
Prominence nano LC system and Autosampler was used for the LC analysis. Fifty 
micrograms cytosolic proteins from MCF-7 cells was loaded onto a zorbax (5 μm, 
5 mm x 0.3 mm) trap column and washed with Solvent A (97.5% Water, 2.5% 
ACN and 0.1% formic acid) for 20 minutes at 10 µL/min. The proteins were then 
fractionated using an Agilent C3 column (5 μm, 150 mm x 0.1 mm) at a flow rate 
of 300 nL/min and a linear gradient of increasing concentration of Solvent B 
(97.5% ACN, 2.4% water and 0.1% formic acid) from 10% to 85% over 90 
minutes. The LC was connected in line with an LTQ-Orbitrap-XL and the 
precursor scans were recorded in the Orbitrap at a resolution of 60,000 at 400 m/z 
with 5 averaged scans. The most abundant signal for each precursor ion was 
subjected to CID fragmentation with activation energy at 25 or ETD with reaction 
time of 5 ms, 10 ms or 20 ms. MS/MS spectra were recorded in the Orbitrap at a 
resolution of 60,000 at 400 m/z 5 averaged scans.  Data dependent analysis was set 
to isolate precursor ions with unassigned charges and charges greater than +4. The 




1E6 for precursor scan and 1E5 for the four MS/MS scans. Dynamic exclusion was 
employed with a repeat count of 1, repeat duration of 15 seconds and exclusion 
duration of 30 seconds.   
Bioinformatics:  Database searching was performed using ProSightPC 
2.0.
55
 The precursor ion and fragment ions were deconvoluted using the 
THRASH
56
 algorithm. The data was searched against a custom UniProt sub 30 
KDa human database (consisting of the sequences of proteins with molecular 
weights less than 30KDa). A precursor mass tolerance was set to 2000 Da and the 
fragment mass tolerance was set at 15 ppm. Post-translational modifications were 
localized on the identifications using ΔM mode and Sequence Gazer on 
ProSightPC 2.0 was used to localize any mass shifts at the N- or C- terminus of the 
protein. Post-translational modifications and mass shifts were investigated 
manually using Sequence Gazer available in the software. The proteins identified 
were automatically assigned an E-value, identifications with E-value lower than 
10E-4 were considered as a strong identification. 
Results and Discussion 
 CID and ETD fragmentation conditions were evaluated based on the 
number of unique proteins identified, the mass range of the proteins identified and 
the number of fragments matched using a custom database and ProSightPC. The 
number of unique proteins identified using ETD was 2 proteins, 6 proteins, and 8 
proteins with a reaction time condition of 5 ms, 10 ms, and 20 ms, respectively. 




proteins. The lists of proteins identified from the four analyses are provided in the 
Appendix Tables 5-8. 
 
Figure 26: Unique protein identification and overlapping proteins from  three ETD 
fragmentation conditions.  
 
  
The two proteins identified using ETD fragmentation with a reaction time 
of 5 ms were identified in the analysis with a  reaction time of 10 ms as well as 20 
ms. There were 3 proteins overlapping between the analyses with reaction time of 
10 ms and 20 ms. The 3 proteins identified in the analysis of the cytoslic proteins 
with reaction time of 20 ms were also sampled by the mass spectrometer in the 







Figure 27: Molecular weights of proteins identified from MCF-7 cytosol on an LC-
MS/MS time scale with CID and ETD fragmentation methods. 
The mass range of proteins identified using CID is 5.0 KDa-14.7 KDa. 
Analysis with ETD allowed unique protein identification from 5.0 KDa to 6.6 KDa 
and 5.0 KDa to 14.7 KDa for analysis with ETD reaction time of 5 and 10 ms, 
respectively. Whereas, the study using ETD reaction time 20 ms allowed for unique 
protein identification from 5.0 KDa to 12.2 KDa.  The 8 proteins identified from 
ETD with a reaction time of 20 ms were also identified using CID.  
The protein thymosin beta-4 was confidently identified in all four analyses. 
The protein sequence and the fragment ions observed for the four analyses are 
shown in Figure 28. The observed mass of the protein in all four cases was 4072.04 































between the theoretical and observed mass was -89.89 Da. Since all the fragments 
identifed were y-ions for CID fragmentation or z-ions for ETD fragmentation, the 
identification of y-ions indicated that the modification was on the N-terminus of the 
protein. Thus, using Sequence Gazer in ProSightPC if the initial methionine (-
131.19 Da) is removed and an acetylation (+42.01 Da) is added to serine residue, 
the number of fragment ions matched increased in all four cases and a lower E-
value was observed increasing the confidence of the identification. Using CID as a 
fragmentation method, 23 b-ions and 13 y-ions were matched with thymosin beta-4 
with a E-value of 6.71E-58. The number of fragments for ETD fragmention with a 
reaction time of 5 ms is 12 c-ions and 5-zion with a E-value of 9.55E-15. Whereas, 
15 c-ions and 7 z-ions with a E-value of 1.39E-30 were matched utlizing ETD 
fragmentation and reaction time of 10 ms and 13 c-ions and 11 z-ion with an E-
value of 1.17E-30 with a reaction time of 20 ms. 
 Although all four analyses identified the protein confidently, the number of 
fragments matched using CID was significantly higher. In addition, many proteins 
identified with CID fragmentation method were not confidently identified with 
ETD fragmentation method. The successful fragmentation using ETD method was 
observed to be very protein dependent, some proteins fragmented more 
successfully compared to others.  The utlization of ETD fragmentation technique 










Figure 28: Protein sequence and fragments observed for thymosin beta-4. 
modifications are highlighted in green were localized using Sequence Gazer in 
ProSightPC, (A) CID fragmentation, (B) ETD fragmentation with reaction time 5 
ms, (C); ETD fragmentation with reaction time of 10 ms, (D) ETD fragmentation 












 Optimized fragmentation conditions and averaged precursor scans play an 
important role in confidently identifying intact proteins from complex mixtures on 
an LC-MS/MS time scale. In the infusion experiment for intact proteins, more 
fragments were matched using lower activation energy with CID and HCD for 
intact proteins infused directly in the mass spectrometer. As the mass of the protein 
increased, internal fragments were observed using the HCD fragmentation 
technique due to which fewer fragment ions were matched. For ETD 
fragmentation, the number of fragments matched increased as the mass of the 
protein increased. In addition, ETD fragmentation favored higher charge states, 
while, CID and HCD fragmentation techniques favored lower charge states. For 
higher molecular weight proteins, the resolution and S/N for the precursor ion 
increases when scans are averaged. The mass range of the proteins increased when 
five averaged scans were acquired for the precursor ion at a resolution of 60,000. In 
the comparison of CID and ETD, a higher number of proteins were identified using 












Chapter 4: Comparative Study of Fractionation Methods for Top-





 The advancement of mass spectrometric instrumentation and fragmentation 
methods has played an important role in the routine LC-MS/MS based analysis of 
mixtures of intact proteins.  Long duty cycle and co-elution of proteins require 
front end fractionation methods are required to reduce the complexity of the 
sample.  The reduction of complexity of the sample aids in increasing the number 
of protein identifications and the mass range accessible in a given analysis.  
Proteins are usually fractionated using gel electrophoresis or chromatographic 
methods. Traditionally, intact proteins are separated using electrophoretic methods 
such as 2D gel electrophoresis or SDS-PAGE. The limitations of these methods are 
laborious nature, biased protein identification, and poor extraction of proteins from 
the gels.
62, 63
 Due to these reasons, separations in which the sample is retained in 
solution are preferred fractionation methods for top-down proteomics.  The three 
in-solution fractionation methods popularly used for intact proteins analysis are the 
Agilent OFFGEL system, molecular weight cut- filters (MWCOF) and the Protein 
Discovery GELFrEE system.  The fractionation using the OFFGEL system is based 
on the isoelectric point of the protein; whereas, fractionation is based on the 




Liquid chromatographic methods are an alternative to electrophoretic 
fractionation of complex mixtures where fractionation is based on physiochemical 
properties of the proteins.  Usually, RP-LC is utilized for analysis as the solvents 
used in this method are compatible with ESI source; thus, RP chromatographic 
columns can be connected in line with the mass spectrometer. Employing 
orthogonal chromatographic techniques, bRP-aRP-LC increases the peak capacity 
and dynamic range of the analysis. The number of proteins identified in bRP-aRP-
LC analysis increased almost 2 fold as demonstrated in chapter 2. 
The objective of the experiment presented in this chapter is to compare the 
effectiveness of GELFrEE electrophoresis, orthogonal bRP-aRP-LC, and molecular 
weight cut-off (MWCO) filters. The evaluation is based   on the number of proteins 
identified and their molecular masses. E. coli lysate is used as the model complex 
mixture.  
Material and Methods 
E. coli Lysate:  Forty milligrams (mg) E. coli (K-12 strain) was lysed by 
vortexing the lyophilized cells in 500 µl of 10% formic acid.  The protein lysate is 
centrifuged for 10 minutes at 14,000 rotations per minute (RPM).  Proteins were 
precipitated with cold acetone through 45 minutes at -20 ºC and precipitated 
proteins were collected by centrifugation at 10,000 g for 20 minutes. The resultant 
pellet was re-suspended in 500 µL of Solvent A (97.5% water, 2.4% acetonitrile, 
0.1% formic acid). The RC/DC assay was used to determine the protein 




Fractionation of E. coli Lysate 
1) High Pressure bRP-LC analysis:  E. coli lysate (300µg) was first 
fractionated on an Xbridge column using solvents with high pH and a flow rate of 
50 µL/min. The two solvents used for the first dimension were: 50 mM ammonium 
hydroxide in water for solvent A and 50 mM ammonium hydroxide in water and 
ACN (2:8) for solvent B.
54
 Reversed phase chromatography was carried out on a 
Thermo Accela LC system with a step gradient of increasing concentration of 
solvent B from 10% to 90% over 60 minutes. The samples were detected with a 
SPD-10A UV spectrometer at 214 nm. A total of five fractions were collected, 
lyophilized and re-suspended in solvent A (97.5% water, 2.4% ACN, 0.1% formic 
acid) for the second dimension. The second dimension was the low pH 
chromatography interfaced to the LTQ-Orbitrap mass spectrometer. This last 
separation was the same for all three of the fractionations evaluated here. 
2) GELFrEE fractionation: Thirty microliters of acetate buffer provided 
by the manufacturer was added to 300 µg of E. coli lysate, followed by reduction in 
53 mM DTT at 50 ºC for 10 minutes. The lysate was loaded onto a 12% Tris-
acetate polyacrylamide cartridge (Expedeon, San Diego, CA) and fractionated 
using manufacturer’s instruction by applying a voltage that increased from  50V to 
85V over two hours. A total of 12 fractions were collected. Each fraction was 
precipitated using CHCl3/MeOH/H2O (4:1:3)
61
 and re-suspended in solvent A 
(97.5% water, 2.4% ACN, 0.1% formic acid) for LC-MS/MS analysis. The 
fractionation was visualized by SDS-PAGE. Ten microliter aliquots from each 




Hercules, CA). The gel was run at 200 V using a BioRad apparatus and stained 
using silver stain. 
3) MWCOF fractionation: Molecular weight cut-off filters (3 KDa and 
30KDa) (Millipore, Billerica, MA) were equilibrated using solvent A (97.5% 
water, 2.4% ACN, 0.1% formic acid). E. coli lysate was centrifuged using a 30KDa 
membrane filter at 14,000 g for 12 minutes. The filtrate (lysate < 30KDa) was then 
centrifuged using a 3 KDa filter at 14,000 g for 30 minutes. The retentate was 
aspirated 30x times with 300 µL of solvent A to increase recovery of the sample. 
The volume was reduced to approximately 50 µL by lyophilizing the sample. 
LC-MS/MS analysis: Seventy-five micrograms of E. coli lysate for the 
control sample or each of the fractions from the three methods was loaded onto a 
Zorbax (5 μm, 5 mm x 0.3 mm) trap column and desalted with solvent A (97.5% 
Water, 2.5% ACN and 0.1% formic acid) for 10 minutes at 15 µL/min. The 
proteins were then fractionated using an Agilent C3 column (5 μm, 150 mm x 0.1 
mm) at a flow rate of 300 nL/min and a linear gradient of increasing concentration 
of solvent B (97.5% ACN, 2.4% water and 0.1% formic acid) from 0% to 85% over 
180 minutes. The LC was connected in line with a LTQ-Orbitrap-XL and the 
precursor scans were recorded in the Orbitrap at a resolution of 60,000 at 400 m/z.  
The most abundant precursor scans were subjected to CID fragmentation in the 
LTQ ion trap with activation energy at 25. MS/MS spectra were recorded in the 
Orbitrap at a resolution of 60,000 at 400 m/z. Data dependent analysis was set to 
isolate precursor ions with either unassigned charges or charges greater than +4. 




seconds and exclusion duration of 300 seconds. The isolation width for the 
precursor ions was set to 10 Da. The automatic gain control (AGC) targets were set 
to 1E6 for precursor scans and 5E5 for MS/MS scans. 
Bioinformatics:  Database searches were performed using ProSightPC 
2.0
55
 against a custom UniProt  E. coli database consisting of proteins with 
molecular weight less than 30KDa. The THRASH
56
 algorithm was used to 
deconvolute both the precursor and fragment ions.  Precursor mass tolerance was 
set to 2500 Da and fragment ions mass tolerance was set to 15 ppm. The ΔM mode 
on ProSightPC 2.0 was used to evaluate mass shifts. Post-translational 
modifications and mass shifts were investigated manually using Sequence Gazer 
available in the software. The proteins identified were automatically assigned an E-












Results and Discussion 
 Fractionation methods for analysis of intact proteins from E. coli lysate 
were evaluated based on the number of proteins identified and mass range of the 
proteins identified using each of the three methods. The GELFrEE and bRP-aRP-
LC methods allow a higher amount of starting material because of the number of 
fractions collected in these analyses. It is easier to get the proteins in-solution using 
GELFrEE fractionation due to the detergent present in the buffers. Fractionation 
using GELFrEE is analogous to SDS-PAGE; however the sample is maintained in 
solution. To visualize the fractionation, a SDS-PAGE of aliquots from the 12 
fractions was run on a polyacrylamide gel visualized with silver stain. The 
molecular weights of the proteins from the GELFrEE analysis increases in every 
fraction. The image of the gel is shown in Figure 29. It shows the narrow mass 






Figure 29: Silver stained 1D gel of the 12 fractions collected from GELFrEE 
analysis. 
Twenty-one unique proteins were identified from analysis of a control 
sample injected directly into the LC-MS/MS without prior fractionation. The 
number of unique proteins identified when MWCOF, GELFrEE, or bRP-aRP-LC 
was implemented as a preliminary fractionation method is 19, 49, and 32, 
respectively. The lists of proteins identified from each of the four analyses are 
provided in the Appendix Tables 9-12. 
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Figure 30: Unique protein identifications and overlapping proteins from E. coli 
lysate for all three fractionation methods. 
As summarized in Figure 30, there were 16 proteins identified in all four 
analyses. The least number of proteins identified was from the MWCOF method. 
All but one protein identified from this analysis was identified in other 
fractionation methods.  I suggest the low number of identifications is due to protein 
adsorption on the membrane. The number of proteins identified uniquely in the 
GELFrEE analysis was 25, while the number of proteins unique to the orthogonal 
bRP-aRP-LC was 9.  Overall, the experiment shows the advantage of fractionating 




GELFrEE analysis and 1.5 fold in the bRP-aRP-LC analysis in comparison to the 
control. 
 
Figure 31: Molecular weight of proteins identified from E. coli lysate with all three 
fractionation methods.  
 The mass range of proteins identified is shown in Figure 31. The control 
sample includes proteins from 4.3 KDa to 10.7 KDa as well as 4.3 KDa to 9.6 KDa 
for the MWCOF method. Analysis with orthogonal RP-RP HPLC allowed the 
identification of unique proteins between 4.3 KDa and 17.1 KDa; whereas, the 
study using GELFrEE method identified proteins with a mass range of 4.2 KDa to 
20.8 KDa. Twenty five percent of the proteins weighed more than 11 KDa in the 




































 Identifications, the GELFrEE fractionation method also enabled increasing the 
mass range of proteins identified.  
 
Table 2: Unique protein identifications between bRP-aRP-LC fractions for analysis 
of E. coli lysate.  
 
Due to the low resolving power of fractionation methods, a given protein 
may be identified in more than one fraction. In the analysis using bRP-aRP-LC, a 
total of 70 proteins were identified from all five fractions. In Table 2, the total 
number of proteins identified in each fraction is indicated in parenthesis, and the 
number of overlapping proteins is indicated in the corresponding boxes.  Thus, 















Fraction 1 (19)     
bRP-aRP-LC 
Fraction 3 (13) 
10 
   
bRP-aRP-LC 




Fraction 5 (16) 
8 6 8 
 
bRP-aRP-LC 
Fraction 6 (15) 





Table 3: Unique protein identifications between fractions using GELFrEE for 
analysis of E. coli lysate. 
 The number of proteins identified in each fraction from the GELFrEE is 
indicated in parenthesis in Table 3, and the number of overlapping proteins 
between fractions is indicated in the corresponding box. A total of 227 proteins 
were identified in the 12 fractions and seventy-eight percent of the identified 





























        GF 
fraction 
5 (24) 21 
       GF 
fraction 
6 (26) 19 21 
      GF 
fraction 
7 (35) 23 23 23 
     GF 
fraction 
8 (29) 21 30 21 25 
    GF 
fraction 
9 (18) 15 14 15 15 15 
   GF 
fraction 
10 (23) 15 13 15 18 17 15 
  GF 
fraction 
11 (22) 16 14 18 19 18 15 17 
 GF 
fraction 




fractions for both bRP-aRP-LC and GELFrEE, there is a higher overlap of proteins 




Figure 32: (A) Precursor Ion spectrum at retention time 107.36 minutes from 
fraction 10 of GELFrEE analysis, (B)  Decharged product ions from m/z 1170.36 
with charge of +7, (C) Protein sequence and fragments observed for UPF0337 







 UPF0337 protein yjbJ was identified with the lowest (best) E-value from all 
four analyses. In fraction 10 of the GELFrEE analysis, the protein eluted at 107.36 
minutes from the C3 HPLC column. The precursor ion spectrum with different 
charge states of the protein is shown in Figure 32A.  The precursor ion of 1170.36 
m/z with charge state of +7 was selected for fragmentation. The decharged 
spectrum of the product ions is shown in Figure 32B. The E-value of the protein 
identified was 1.05E-53 with  36 b-ions and 51 y-ions. The experimental mass of 
the protein was 8320.1 Da, which matched the theoretical mass of the protein 
predicted from the gene sequence. 
 
Figure 33 (A): Precursor ion spectrum at retention time 153.06 from fraction 10 of 
GELFrEE analysis for cell division protein ZapB (B) Product ions from m/z 











Figure 34: (A) Protein sequence and fragments observed from cell division protein 
ZapB identified with ProSightPC and E-value of 7.05E-45 and mass difference of 
363 Da compared to the theoretical mass, (B) Modifications are localized and 
highlighted in green using Sequence Gazer in ProSightPC with a recalculated E-






























































































Cell division protein ZapB was identified in fraction 6 from the GELFrEE 
analysis of the E. coli lysate.  The precursor ion spectrum at 153.06 minutes and the 
product ion spectrum for ions of m/z 1031.09 with a charge state of +9 are shown 
in Figure 33. The protein was identfied with a 48 y-ions and a mass of  9265.72 Da 
and with an E-value of 7.05E-45  A mass difference of -363 Da existed between the 
observed mass and the theortical mass of  9628.81 Da. This mass difference 
corresponds to the mass of the first three amino acid residues,  two methionine 
(131.09 Da each) and threonine (101 Da).  If this change is applied to the protein 
using Sequence Gazer, the E-value drops to 3.49E-75. The number of matched 










Figure 35: (A) Precursor ion spectrum at retention time 131.45 from fraction 1 of 
bRP-aRP-LC analysis of DNA-directed RNA polymerase subunit omega (B) 







































Figure 36: (A) Protein sequence and fragments observed from DNA-directed RNA 
polymerase subunit omega identified by ProSightPC with an E-value of 5.66E-21 
and mass difference of -131 Da compared to the theoretical mass, (B) PTMs 
localized and highlighted in green using Sequence Gazer in ProSightPC with a 
recalculated E-value of  2.5E-34. 
 While there were many overlapping proteins between samples, some 
proteins identified were unique to a given fractionation method. DNA-directed 
RNA polymerase subunit was identified only from bRP-aRP-LC analysis. The 






at this retention time is shown in Figure 35A. The ion with m/z 843.12 with a 
charge state of +12 was fragmented, the product ions and the decharged spectrum 
are shown in Figure 35B and Figure 35C, respectively. The observed mass for this 
protein was 1099.33 Da which is 131 Da less than the theoretical mass of 10230.4 
Da. Twenty–three y-ions was assigned using ProSightPC. The E-value was 5.66E-
21 for the protein identification. The mass difference between the theoretical and 
observed mass was -131 Da, which is assigned to the truncation of the initial 
methionine. When this change in mass was applied to the N-terminus of the 
protein, an addition of 9 b-ions were matched and the recalculated E-value was 


















 Fractionation of complex mixtures reduces the sample complexity and 
increases the number of identifications and mass range of the proteins. Comparing 
the three fractionation methods, GELFrEE resulted in the most identifications and 
the highest mass range. In the case of MWCOF method, the low recovery of 
proteins from the membrane leads to fewer protein identifications. Seventy-eight 
percent of proteins were identified in more than one fraction in the case of 
GELFrEE method and fifty-eight percent in the case of the bRP-aRP-LC method. 
Both the GELFrEE and bRP-aRP-LC workflows allow larger number of sample to 
be fractionated, up to 500 µg.  Additionally, it is easier to dissolve proteins using 
GELFrEE fractionation due the detergents present in the buffer. A total of 61unique 
proteins were identified in the control and the three pre-fractionation workflows. Of 
these, only 12 proteins were found not to be modified and 48 proteins were found 













Chapter 5: Top-Down Analysis of Intact proteins of Extracellular 






Extracellular vesicles (EVs) are small membranous vesicles released from 
cells under normal and pathological conditions and range from 10 nm-1000 nm in 
diameter. The EVs have many biological functions, including immune response, 
antigen presentation, and intercellular communication.
64
 EVs are of interest 
because of the specific mechanisms whereby they are actively released from cells, 
their involvement in cell-to-cell signaling and their utility as markers of disease.
65
 
The composition of these vesicles reflects the origin parent cell and usually 
contains membrane, nuclear and cytosolic proteins.
64
 Myeloid-derived suppressor 
cells (MDSC) accumulate in tumor microenvironment during tumor growth in 
lymphoid organs, blood and tumor tissue.
66
  It has been shown experimentally that 
the MDSC cells contribute to suppression of T-cell activation. MDSC suppress 
both innate and adaptive immune responses to tumor growth and prevent effective 
immunotherapy.
67
 They shed extracellular vesicles, which we hypothesize act as 
intercellular communicators in the tumor microenvironment. 
In this experiment we apply the developed effective top-down workflow, 
including optimized fractionation, front end chromatographic separation and 




EVs shed by MDSC. EVs are shed from MDSC cells that are isolated from the 
blood of BALB/c mice that are carrying 4T1/IL-1β mammary carcinoma cells. 
Top-down analysis of intact proteins from these extracellular vesicles was 
undertaken to identify low mass protein cargo and to characterize post-translational 
modifications. Current understanding of EV subtypes, biogenesis, cargo and 
mechanisms of transporting proteins is incomplete. Thus, intact protein analysis of 
the EVs is useful for determining whether post translational modifications may play 
a role in the formation or function in the tumor microenvironment.  
 
Material and Methods 
 
Intact protein from extracellular vesicle: Extracellular vesicles were 
provided by Dr. Suzanne Ostrand-Rosenberg’s lab at UMBC. Myeloid-derived 
suppressor cells (MDSC) were harvested from the blood of BALB/c mice injected 
with 4T1/IL-1β mammary carcinoma cells. Purified MDSC were maintained 
overnight at 37 ºC with 5% CO2 in serum free medium. Extracellular vesicles (EVs) 
were isolated with a 10 mL 0.25 M to 2.0 M sucrose density gradient, and 
resuspended in water. EVs were lysed in 8M urea in the presence of a protease 
inhibitor cocktail (Sigma Aldrich, St. Louis, MO). The protein concentration was 
determined using the RC/DC assay.  
GELFrEE fractionation: Three hundred micrograms of intact protein was 
precipitated using using CHCl3/MeOH/H2O (4:1:3).
61
 The resulting pellet was re-




reduced for 10 minutes at 50 ºC in 53 mM DTT. The sample was fractioned by 
tubular electrophoresis using a 12% Tris-acetate polyacrylamide cartridge 
(Expedeon, San Diego, CA) and applying a voltage that increased from 50V to 85V 
over two hours. A total of 12 fractions were collected. Each fraction was 
precipitated using CHCl3/MeOH/H2O (4:1:3)
61
 followed by resuspension in solvent 
A (97.5% water, 2.4% ACN, 0.1% formic acid) for LC-MS/MS analysis. The 
fractionation was visualized by SDS-PAGE. Ten microliter aliquots from each 
fraction were electrophoresed on an 8-16% Tris-HCl polyacrylamide gel (BioRad, 
Hercules, CA). The gel was run at 200 V using a BioRad apparatus and stained 
using silver stain (Pierce, Rockford, IL). 
LC-MS/MS analysis: Each fraction was desalted with solvent A (97.5% 
Water, 2.5% ACN and 0.1% formic acid) for 15 minutes at 10 µL/min on a Zorbax 
column (5 μm, 5 mm x 0.3 mm). Reversed phase chromatography was carried out 
on a Shimadzu Prominence LC system and autosampler using an Agilent C3 
column (5 μm, 150 mm x 0.1 mm) at a flow rate of 300 nL/min and a linear 
gradient of increasing concentration of solvent B (97.5% ACN, 2.4% water and 
0.1% formic acid) from 0% to 85% over 200 minutes. The LC was connected in 
line with an LTQ-Orbitrap-XL, and the precursor scans were recorded in the 
Orbitrap at a resolution of 60,000 at 400 m/z (5 averaged).  The most abundant 
precursor ions were fragmented using CID with a nominal activation energy of 25 
in the LTQ ion trap. MS/MS spectra for the most abundant ion were recorded in the 
Orbitrap at a resolution of 60,000 at 400 m/z.  The automatic gain control (AGC) 




dependent analysis was set to isolate precursor ions with either unassigned charges 
or charges greater than +4. Dynamic exclusion was employed with a repeat count 
of 2, repeat duration of 240 seconds and exclusion duration of 300 seconds. The 
isolation width for the precursor ions was set at 10 Da.  
Bioinformatics:  Database searches were performed using ProSightPC 
2.0
55
 against a custom UniProt mouse database consisting of proteins with 
molecular weight less than 30KDa. The precursor and fragment ions were 
deconvoluted using the THRASH
56
 algorithm in the program. The precursor mass 
tolerance was set to 2500 Da and fragment ions mass tolerance was set to 15 ppm. 
The ΔM mode on ProSightPC 2.0 was used to evaluate mass shifts.  Sequence 
Gazer tool was used to localize post-translational modifications and mass shifts. 
The proteins identified were automatically assigned an E-value. Identifications with 
E-value lower than 10E-4 were considered as a strong identification.  
 
Result and Discussion 
A total of forty unique proteins were identified in the bioinformatic 
analysis. The list of proteins identified from the analysis is listed in Table 6. The 
mass range of proteins identified using one averaged precursor ion scan is 5 KDa-
16 KDa. Modifications were observed on thirty-nine of the forty proteins identified. 






















14 10044.3 9955.28 -89.02 5.12E-07 P14069 
Protein S100-
A6 
25 10288.1 10200.06 -88.04 5.77E-14 P27005 
Protein S100-
A8 
14 10288.1 10330.11 42.01 7E-11 P27005 
Protein S100-
A8 
24 10288.1 10571.21 283.11 2.33E-12 P27005 
Protein S100-
A8 
21 10288.1 10139.12 -148.98 1.74E-13 P27005 
Protein S100-
A8 
50 10288.1 10157.03 -131.07 8.2E-45 P27005 
Protein S100-
A8 
33 10288.1 10173.02 -115.08 1.24E-23 P27005 
Protein S100-
A8 
34 10288.1 10288.1 0 1.27E-20 P27005 
Protein S100-
A8 
11 14227.8 12024.6 -2203.2 1.92E-05 P70696 
Histone H2B 
type 1-A 
22 13943.6 12228.75 -1714.85 3.57E-10 Q64475 
Histone H2B 
type 1-B 
21 13943.6 13796.46 -147.14 2.52E-11 Q64475 
Histone H2B 
type 1-B 
17 13897.6 13785.45 -112.15 1.45E-05 Q6ZWY9 
Histone H2B 
type 1-C/E/G 
14 13927.6 13785.5 -142.1 9.18E-07 P10854 
Histone H2B 
type 1-M 
19 13927.6 13779.63 -147.97 1.08E-09 P10854 
Histone H2B 
type 1-M 
14 13911.6 13798.41 -113.19 4.81E-05 Q64525 
Histone H2B 
type 2-B 
26 14126.9 14037.93 -88.97 8.54E-13 P22752 
Histone H2A 
type 1 
18 14086.9 13998.74 -88.16 1.8E-08 Q6GSS7 
Histone H2A 
type 2-A 
27 14112.9 14037.89 -75.01 6.53E-12 Q8BFU2 
Histone H2A 
type 3 


























16 13927.6 13779.56 -148.04 5.18E-08 P10853 
Histone H2B 
type 1-F/J/L 
22 13927.6 13796.46 -131.14 4.22E-12 P10853 
Histone H2B 
type 1-F/J/L 
20 13911.6 13796.45 -115.15 1.49E-10 Q64478 
Histone H2B 
type 1-H 
17 13927.6 13766.61 -160.99 7.35E-06 P10854 
Histone H2B 
type 1-M 
24 13983.6 13796.51 -187.09 2.6E-09 Q8CGP2 
Histone H2B 
type 1-P 
19 13983.6 13811.44 -172.16 2.77E-06 Q8CGP2 
Histone H2B 
type 1-P 
20 13911.6 13766.56 -145.04 5.32E-06 Q64525 
Histone H2B 
type 2-B 
12 13911.6 13796.58 -115.02 2.96E-05 Q64525 
Histone H2B 
type 2-B 
18 15394.5 15305.58 -88.92 9.43E-06 P68433 Histone H3.1 
18 15378.5 13026.14 -2352.36 5E-08 P84228 Histone H3.2 
20 15318.5 13026.22 -2292.28 5.08E-16 P84244 Histone H3.3 
12 15318.5 15291.43 -27.07 2.07E-07 P84244 Histone H3.3 
15 15348.5 13025.14 -2323.36 1.52E-06 Q9FX60 
Histone H3-like 
1 
19 15348.5 13807.66 -1540.84 6.22E-09 Q9FX60 
Histone H3-like 
1 
25 11360.4 11301.34 -59.06 3.66E-15 P62806 Histone H4 
49 11360.4 9044.04 -2316.36 2.92E-44 P62806 Histone H4 
13 11360.4 9705.39 -1655.01 8.98E-06 P62806 Histone H4 
19 11360.4 11329.38 -31.02 1.65E-05 P62806 Histone H4 
12 6269.31 5621.02 -648.29 3.6E-05 P47945 
Metallothionein
-4 









The S100 family of proteins is expressed in immature cells of myeloid 
lineage including myeloid-derived suppressor cells. The members of the S100 
family are calcium binding proteins and act as inflammatory mediators when 
released by the cells of myeloid origin. These proteins are elevated in inflammatory 
conditions and are chemotactic and chemokines.
68
 In addition, they are unregulated 
in many tumors and serve as markers in immune cells within the tumor 
microenvironment.
69
 The top-down analysis of these vesicles allows the 
identifications of various proteoforms of proteins from the S100 family. In our 
analysis the two proteins identified from this family are S100 A6 and S100 A8.   
S100 A6 was identified at 100.39 minutes in fraction 2. The intact mass of 
the protein was observed to be 9,955.28 Da which is 89.02 Da less than the 
theoretical mass of 10,044.3 Da. Using the Sequence Gazer tool in Prosigh PC this 
mass difference was localized to truncation of the N-terminal methionine and 
acetylation of the alanine residue.  The protein was matched with an E-value of 
5.12E-07. The precursor and the product ion spectrum, as well as the protein 
sequence with the fragments matched and the modifications observed are showin in 







Figure 37: (A) Precursor ion spectrum at retention time 100.39 minutes from 
fraction 2 of protein S100 A6 (B) Product ions from m/z 997.14 with charge of +10 
(C) Decharged product ion scan. (D) Protein sequence, fragments identified and 
modification localized using ProSightPC with an E-value of 5.12E-07. The mass 








There were 6 different proteoforms of S100 A8 identified from fraction 2, 3 
and 4. The first proteoform identified in fraction two and the precursor and product 
ion spectrum is shown in Figure 38A-C. The protein was identified with an E-value 
of 1.27E-20 and 34 fragments matched. There was no mass difference between the 
observed and theoretical mass of the protein. The protein sequence and the 
fragments matched are shown in Figure 38D. 
The second proteoform of S100 A8 was identified in fraction 2. The mass 
difference between the observed and theoretical mass was -88.04 Da. This mass 
difference was localized using Sequence Gazer by truncation of the initial 
methionine and acetylation of the serine residue. There were 25 fragments matched, 
and the protein was identified with an E-value of 5.77E-14. The precursor ion 
spectrum, product ion spectrum as well as the modification and the fragments 
matched are shown in Figure 39. 
A third proteoform of S100 A8 was also identified in fraction 2. The 
observed mass of the protein was 10,330.11 Da which is 42.01 Da higher than the 
theoretical mass of 10288.1 Da.  The modification on this protein was localized as 
an acetylation on the N-terminal methionine residue. The proteoform was identified 
with an E-value of 7E-11 and 14 matched fragments. The precursor ion spectrum, 
product ion spectrum as well as the modification and the fragments matched are 
shown in Figure 40. 
A fourth proteoform of S100 A8 was identified in fraction 3, with a mass of 




spectrum, product ion spectrum, as well as the modification and the fragments 
matched are shown in Figure 41. The modification was localized using Sequence 
Gazer in ProSightPC at the first three amino acid residues. There are two possible 
modifications for this proteoform of S100 A8. The first is removal of the initial 
methionine and proline residue, and phosphorylation of the third serine residue. A 
second possible of this modification is loss of the initial methionine residue and 
neutral loss of water. The protein was identified with an E-value of 1.74E-13 and 
21 matched fragments.  
The fifth proteoform of S100 A8 was identified in fraction 4. The mass of 
the protein observed was 10,157.03 Da which is 131.07 Da less than the theoretical 
mass of 10,288.1 Da. The removal of the initial methionine from the protein was 
localized using Sequence Gazer in ProSightPC; the protein was identified with an 
E-value of 8.2E-45 and 50 matched fragments. The precursor ion spectrum, product 
ion spectrum as well as the modification and the fragments matched for this 
proteoform are shown in Figure 42. 
Protein S100 A8 with an observed mass of 10173.02 was identified in 
fraction 3. The mass difference between the theoretical mass and observed mass 
was -115.08 Da. This mass difference is interpreted as resulting from the removal 
of the initial methionine and oxidation of 37
th
 methionine residue. The localization 
of these modifications using ProSightPC yielded 30 matched fragments and an E-
Value of 1.24E-23. The precursor ion spectrum, product ion spectrum as well as the 






Figure 38: (A) Precursor ion spectrum at retention time 121.74 minutes from 
fraction 2 assigned to  protein S100 A8 (B) Product ions from m/z 936.75 with 
charge of +11 (C); Decharged product ion scan. (D) Protein sequence assigned 










Figure 39: (A) Precursor ion spectrum at retention time 91.27 minutes from fraction 
2 assigned as protein S100 A8 (B) Product ions from m/z 1021.60 with charge of 
+10 (C) Decharged product ion scan. (D) Protein sequence, fragments identified 
and modification localized using ProSightPC with an E-value of 5.77E-14. The 










Figure 40: (A) Precursor ion spectrum at retention time 93.66 minutes from fraction 
2, assigned as protein S100 A8 (B) Product ions from m/z 940.64 with charge of 
+11 (C) Decharged product ion scan. (D) Protein sequence, fragments identified 
and modification localized using ProSightPC with an E-value of 7E-11. The mass 












Figure 41: (A) Precursor ion spectrum at retention time 117.63 minutes from 
fraction 3, assigned as protein S100 A8 (B) Product ions from m/z 846.43 with 
charge of 12 (C) Decharged product ion scan. (D) Protein sequence, fragments 
identified and modification localized using ProSightPC with an E-value of 1.74E-












Figure 42: (A) Precursor ion spectrum at retention time 119.28 minutes from 
fraction 4 assigned as S100 A8 (B) Product ions from m/z 783.78 with charge of 
+13 (C) Decharged product ion scan. (D) Protein sequence, fragments identified 
and modification localized using ProSightPC with an E-value of 8.2E-45. The mass 












Figure 43: (A) Precursor ion spectrum at retention time 118.00 minutes from 
fraction 3 assigned as S100 A8 (B) Product ions from m/z 849.26 with charge of 
+12 (C) Decharged product ion scan. (D) Protein sequence, fragments identified 
and modification localized using ProSightPC with an E-value of 1.24E-23. The 









The other family of proteins that were identified in this analysis was 
histones. They are important chromatin proteins that are associated with the DNA, 
which package and order the DNA in to nucleosomes. The histone proteins have a 
wide variety of post-translational modifications, including acetylation, methylation 
phosphorylation and ubiquitylation. Although there only 4 core histones H4, H2B, 
H2A and H3 each family has many potential isoforms due to sequence variation 
and observed post-translational modifications.
70
 The analyses of the intact proteins 
of EVs by high resolution mass spectrometry allow the identifications of these 
intact proteins as well as their post translational modifications. 
The three proteoforms identified for histone H2A were histone 2A type 1, 
histone 2A type 2-A and histone 2A.x. The three proteins have very similar 
sequences and differ only by a few amino acid residues. Histone 2A type 1 and 
histone 2A type 2-A were identified in fraction 6 of the tubular electrophoresis, and 
histone 2A.x was identified in fraction 7. In all three cases, the modifications were 
observed on the N-terminus of the protein, with removal of the initial methionine 
and acetylation of the serine residue. The precursor ion spectrum, product ion 
spectrum as well as the modification and the fragments matched are for histone 2A 






Figure 44: (A) Precursor ion spectrum at retention time 104.37 minutes from 
fraction 6 assigned to histone 2A type 1 (B) Product ions from m/z 827.24 with 
charge of +17 (C) Decharged product ion scan. (D) Protein sequence, fragments 
identified and modification localized using ProSightPC with an E-value of 8.54E-











Figure 45: (A) Precursor ion spectrum at retention time 101.56 minutes from 
fraction 6 histone assigned to 2A type 2-A (B) Product ions from m/z 824.89 with 
charge of +17 (C) Decharged product ion scan. (D) Protein sequence, fragments 
identified and modification localized using ProSightPC with an E-value of 1.8E-08. 












Figure 46: (A) Precursor ion spectrum at retention time 101.56 minutes from 
fraction 7 assigned to histone 2A.x (B) Product ions from m/z 753.62 with charge 
of +20 (C) Decharged product ion scan. (D) Protein sequence, fragments identified 
and modification localized using ProSightPC with an E-value of 1.31E-05. The 










Application of an effective work flow, including optimized fractionation, 
front end chromatographic separation and activation, allowed the identification of 
40 proteins in EVs shed by MSDC cells. Modifications were observed on 39 of the 
40 proteins identified. The two main families of proteins identified in this analysis 
were histones and S100. Twenty nine proteoforms were identified from the forty 
proteins were histone proteins. The analysis enabled the identification of six 
proteoforms of S100 A8.  Most of the proteins identified are small basic proteins; 
the proteins, which ionize well with ESI.  The sample preparation for the analysis is 

























Chapter 6: Conclusions 
 
 
The field of proteomics predominantly uses the bottom-up approach for 
complex mixture analysis. Bottom up strategies identify the presence of many 
hundreds of proteins. However, top-down strategies provide more information 
about each protein. Due to the increased availability of robust high resolution mass 
analyzers such as the Orbitrap and TOF, it is possible for more laboratories to 
analyze intact protein in complex mixtures. The work in this thesis shows that, on 
an LC-MS/MS time scale, it is possible to identify up to 50 proteins in a given 
analysis. The mass range of the proteins identified was 4 KDa to 22 KDa.  
Pre-fractionation of complex mixtures prior to intact LC-MS/MS analysis 
increases the number of identifications. Optimization of experimental conditions 
for front end fractionation of complex mixtures increases the number of 
identification. The HPLC columns are not as effective for intact proteins as for 
peptide analysis. In our evaluation none of the 3 activation methods has a clear 
advantage. Our Orbitrap has sufficient resolution, but seems to have an upper mass 
limit of 25 KDa. In addition, only limited choices in software are currently 
available for intact protein analysis. Specialized software is required to deconvolute 
the precursor ions and fragment ions.  The next iteration for this optimized work 







Table 1: Proteins identified with 1D LC-MS/MS analysis of E. coli. lysate from  
1D-LC-MS/MS 











Number Protein Description 
13 4961.72 5092.75 1.88E-17 131.03 253973439 
30S ribosomal subunit 
protein S22 
8 6236.58 6250.58 0.000055 14 253975465 
50S ribosomal protein 
L33 
13 6311.39 6311.34 1.46E-12 -0.05 254161195 
50S ribosomal protein 
L32 
6 6460.54 6591.56 4.78E-06 131.02 253975191 
hypothetical protein 
ECB_03213 
6 7137.94 7284.94 6.23E-06 147 253975141 
50S ribosomal protein 
L29 
12 7145.6 7145.55 7.4E-13 -0.05 254160455 
hypothetical protein 
ECB_00336 
8 7266.72 7266.7 2.42E-08 -0.02 253973783 
stress protein, member 
of the CspA-family 
8 8152.25 8153.29 6.33E-10 1.04 253974103 
hypothetical protein 
ECB_02117 
6 8189.05 8319.99 3.57E-05 130.94 254163981 
putative stress-
response protein 
10 8747.19 8762.2 3.43E-10 15.01 253973797 
hypothetical protein 
ECB_01807 
13 9088.95 9220.01 1.85E-14 131.06 253972411 
HU, DNA-binding 
transcriptional 
regulator, beta subunit 
14 9219.99 9219.89 5.54E-17 -0.1 254160510 
transcriptional 
regulator HU subunit 
beta 

















Number Protein Description 
regulator, alpha 
subunit 
5 10612.6 10743.54 5.07E-05 130.94 253975046 
predicted ribosome-
associated, sigma 54 
modulation protein 
5 11028.5 11028.53 3.49E-05 0.03 253976002 
unknown, RNA-











































6 4230.41 4230.38 1.53E-07 -0.03 254163227 
50S ribosomal 
protein L36 




25 6236.58 6250.57 5.38E-37 13.99 253975465 
50S ribosomal 
protein L33 
23 6311.39 6311.37 2.24E-32 -0.02 254161195 
50S ribosomal 
protein L32 
10 6406.6 6406.59 6.12E-11 -0.01 253975131 
50S ribosomal 
protein L30 
17 6503.26 6541.16 7.20E-18 37.9 254161067 
ribosome 
modulation factor 




6 6851.65 6878.67 6.33E-05 27.02 253974528 
carbon storage 
regulator 
















17 7266.72 7266.67 1.67E-21 -0.05 253973783 
stress protein, 
member of the 
CspA-family 
7 7267.59 7265.69 3.48E-06 -1.9 253975380 
unknown, major 
cold shock protein 
17 7268.98 7268.89 1.92E-21 -0.09 253975141 
50S ribosomal 
protein L29 



































10 8189.05 8320.06 1.72E-10 131.01 254163981 
putative stress-
response protein 
12 8363.69 8362.64 2.83E-13 -1.05 254163012 
30S ribosomal 
protein S21 
6 8709.67 8840.68 6.81E-07 131.01 253973803 
DNA polymerase 
III, theta subunit 




18 8808.32 8807.28 9.37E-24 -1.04 254161302 
cation transport 
regulator 
16 9000.59 8998.53 1.37E-20 -2.06 253975441 glutaredoxin 3 


















20 9547.28 9548.25 4.36E-20 0.97 253972050 
30S ribosomal 
protein S20 
8 10131.5 10130.5 2.08E-08 -1 254163109 
30S ribosomal 
protein S15 
15 10203.3 10203.26 1.08E-16 -0.04 254161177 
anti-sigma28 factor 
FlgM 
12 10292.7 10292.65 4.67E-12 -0.05 254163244 
30S ribosomal 
protein S19 





























7 10464.4 10594.41 6.72E-07 -0.99 254161330 YciI-like protein 
15 11178.3 11178.18 1.63E-19 -0.12 254163237 
50S ribosomal 
protein L24 


























Table 3: Proteins identified from LC-MS/MS analysis of cytosol from MCF-7 

























36 5049.52 4960.52 -89 3.7E-54 P62328 
Thymosin beta-
4 
11 6643.82 6643.81 -0.01 1.6E-09 P62861 
40S ribosomal 
protein S30 
16 6895.64 6937.63 41.99 2.3E-21 P84101 
Small EDRK-
rich factor 2 









16 7836.2 7878.24 42.04 5.1E-19 P62857 
40S ribosomal 
protein S28 
9 8919.42 7136.57 
-




9 9065.95 8556.69 -509.26 0.00001 Q15843 NEDD8 





22 10038 9949.01 -88.99 3.6E-26 P07108 
Acyl-CoA-
binding protein 
25 11523.2 11532.17 8.97 1E-15 P20962 Parathymosin 
38 11732.8 11643.81 -88.99 1.2E-49 P31949 
Protein S100-
A11 






Table 4: Proteins identified from LC-MS/MS analysis of cytosol from MCF-7 





















37 5049.52 4960.48 -89.04 6.22E-56 P62328 
Thymosin beta-
4 
12 6643.82 6643.82 0 8.01E-13 P62861 
40S ribosomal 
protein S30 
16 6895.64 6937.66 42.02 1.58E-20 P84101 
Small EDRK-
rich factor 2 





16 7836.2 7878.22 42.02 7.05E-20 P62857 
40S ribosomal 
protein S28 
9 9065.95 8537.64 -528.31 7.61E-05 Q15843 NEDD8 





12 10038 8440.59 
-
1597.41 9.25E-12 P07108 
Acyl-CoA-
binding protein 





10 11523.2 11434.23 -88.97 4.07E-11 P20962 Parathymosin 
32 11732.8 11643.8 -89 1.88E-42 P31949 
Protein S100-
A11 
24 12196 11978.95 -217.05 5.93E-31 P06454 
Prothymosin 
alpha 






Table 5: Proteins identified from 1D LC-MS/MS analysis of cytosol from MCF-7 
cancer cells with five averaged scans for the precursor ion using ETD 

















22 6643.82 6643.82 0 5.59E-11 P62861 
40S ribosomal 
protein S30 
18 5049.52 4960.49 
-
89.03 5.27E-10 P62328 Thymosin beta-4 
 
 
Table 6: Proteins identified from 1D LC-MS/MS analysis of cytosol from MCF-7 
cancer cells with five averaged scans for the precursor ion using ETD 




























31 6895.64 6937.64 42 7E-17 P84101 
Small EDRK-
rich factor 2 





























Table 7: Proteins identified from 1D LC-MS/MS analysis of cytosol from MCF-7 
cancer cells with five averaged scans for the precursor ion using ETD 






















11 P62328 Thymosin beta-4 









rich facto 2 
















































Table 8: Proteins identified from 1D LC-MS/MS analysis of cytosol from MCF-7 






















12 6643.82 6643.82 0 8.01E-13 P62861 
40S ribosomal 
protein S30 





rich factor 2 
16 7836.2 7878.22 42.02 7.05E-20 P62857 
40S ribosomal 
protein S28 
13 7836.2 7878.18 41.98 6.75E-08 P62857 
40S ribosomal 
protein S28 
9 9065.95 8537.64 -528.31 7.54E-05 Q15843 NEDD8 
12 9387.06 9256.02 
















10 11523.2 11434.23 -88.97 4.07E-11 P20962 Parathymosin 
32 11732.8 11643.8 -89 1.88E-42 P31949 
Protein S100-
A11 
28 11732.8 11643.77 -89.03 1.1E-30 P31949 
Protein S100-
A11 
24 12196 11978.95 -217.05 5.93E-31 P06454 
Prothymosin 
alpha 






























17 4361.45 4359.42 -2.03 5.93E-08 B1X6F1 
50S ribosomal 
protein L36 






8 5879.77 5748.79 -130.98 7.35E-06 P56614 
Uncharacterize
d protein ymdF 
53 6367.62 6250.61 -117.01 6.74E-33 P0A7N9 
50S ribosomal 
protein L33 
41 6442.43 6327.39 -115.04 1.56E-30 B7NAW5 
50S ribosomal 
protein L32 
20 6537.65 6406.63 -131.02 4.67E-13 B1IPZ7 
50S ribosomal 
protein L30 
46 6851.65 6878.74 27.09 3.77E-31 B1IUY3 
Carbon storage 
regulator 
22 7268.98 7268.08 -0.9 2.6E-13 P0A7M7 
50S ribosomal 
protein L29 
39 7276.64 7145.62 -131.02 4.11E-29 P0AAN7 
Uncharacterize
d protein yaiA 
35 7397.76 7266.76 -131 6.15E-20 P0A9Y7 
Cold shock-like 
protein CspC 
24 7865.92 7861.86 -4.06 1.13E-12 B7N2S7 
50S ribosomal 
protein L31 
25 7990.25 7859.3 -130.95 1.66E-07 P0C265 
Uncharacterize
d protein yibT 
43 8283.29 8152.24 -131.05 2.21E-40 B7MXK3 
UPF0352 
protein YejL 
72 8320.09 8320.07 -0.02 5.96E-59 P68206 
UPF0337 
protein yjbJ 
24 8872.63 8872.63 0 2.63E-11 P0ACW6 
Uncharacterize
d protein ydcH 






























70 9396.72 9265.71 -131.01 2.05E-41 B6I4S1 
Cell division 
protein ZapB 




23 9889.14 11177.38 
1288.2
4 1.04E-14 P75694 
Uncharacterize
d protein YahO 












































50S ribosomal protein 
L36 




50 6367.62 6250.61 -117.01 3.05E-33 P0A7N9 
50S ribosomal protein 
L33 
34 6442.43 6327.36 -115.07 1.82E-31 B7NAW5 
50S ribosomal protein 
L32 
33 6537.65 6406.61 -131.04 5.68E-18 B1IPZ7 
50S ribosomal protein 
L30 
23 6594.53 6591.57 -2.96 3.68E-11 P0ADX6 
Uncharacterized 
protein yhfG 
49 6851.65 6878.74 27.09 1.98E-34 B1IUY3 
Carbon storage 
regulator 
38 7268.98 7268.97 -0.01 7.24E-33 P0A7M7 
50S ribosomal protein 
L29 O 
47 7276.64 7145.62 -131.02 1.71E-42 P0AAN7 
Uncharacterized 
protein yaiA 
21 7397.76 7266.71 -131.05 2.07E-11 P0A9Y7 
Cold shock-like 
protein CspC 
19 7865.92 7861.91 -4.01 1.09E-10 B7N2S7 
50S ribosomal protein 
L31 
48 7990.25 7859.26 -130.99 6.59E-33 P0C265 
Uncharacterized 
protein yibT 
26 8283.29 8152.21 -131.08 2.84E-15 B7MXK3 
UPF0352 protein 
YejL 
74 8320.09 8320.07 -0.02 3.83E-61 P68206 UPF0337 protein yjbJ 
31 8872.63 8872.63 0 6.47E-17 P0ACW6 
Uncharacterized 
protein ydcH 
28 9184.95 10643.45 1458.5 5.84E-19 P0A7T4 
30S ribosomal protein 
S16 
28 9219.99 10019.22 799.23 2E-16 P0ACF4 
DNA-binding protein 
HU-beta 
58 9396.72 9265.67 -131.05 5.31E-40 B6I4S1 
Cell division protein 
ZapB 

































17 5879.77 5748.79 -130.98 5.41E-15 P56614 
Uncharacterized 
protein ymdF 
27 6367.62 6250.64 -116.98 9.52E-31 P0A7N9 
50S ribosomal 
protein L33 
23 6442.43 6311.43 -131 6.99E-21 B7NAW5 
50S ribosomal 
protein L32 
25 6537.65 6406.6 -131.05 6.46E-10 B1IPZ7 
50S ribosomal 
protein L30 
42 6550.21 6679.26 129.05 5.72E-16 Q1RAY1 
UPF0181 
protein yoaH 
51 6851.65 6878.74 27.09 1.42E-37 B1IUY3 
Carbon storage 
regulator 
29 7268.98 7266.76 -2.22 9.74E-08 P0A7M7 
50S ribosomal 
protein L29 
50 7276.64 7145.59 -131.05 5.02E-38 P0AAN7 
Uncharacterized 
protein yaiA 
47 7397.76 7266.72 -131.04 1.55E-50 P0A9Y7 
Cold shock-like 
protein CspC 
24 7398.63 7267.54 -131.09 8.2E-19 P0A9Y0 
Cold shock 
protein CspA 
50 7990.25 7859.26 -130.99 8.52E-42 P0C265 
Uncharacterized 
protein yibT 




coli O81 (strain 
77 8320.09 8320.11 0.02 4.75E-66 P68206 
UPF0337 
protein yjbJ 
31 8409.62 8409.68 0.06 4.85E-23 P0AD41 
Uncharacterized 
protein ypeB 























66 8747.19 8745.13 -2.06 1.93E-50 P64503 
Uncharacterized 
protein yebV 
33 8872.63 8872.62 -0.01 1.08E-23 P0ACW6 
Uncharacterized 
protein ydcH 
17 8890.53 7702.93 -1187.6 3.19E-09 P0AAX7 
Uncharacterized 
protein McbA 
16 8939.36 8808.31 -131.05 9.76E-07 P0AE64 
Cation transport 
regulator 
39 9113.74 9113.77 0.03 1.1E-20 P0AA06 
Phosphocarrier 
protein HPr 
24 9184.95 9184.91 -0.04 0.000047 P0A7T4 
30S ribosomal 
protein S16 
48 9219.99 9219.98 -0.01 4.37E-28 P0ACF4 
DNA-binding 
protein HU-beta 
37 9379.81 9400.71 20.9 1.37E-20 P0AB63 Protein yciN 
71 9396.72 9265.71 -131.01 3.17E-59 B6I4S1 
Cell division 
protein ZapB 









52 10595.4 10617.4 22 3.31E-45 P0AB55 Protein yciI 









14 15207.4 15550.46 343.06 3.95E-06 B7NGD4 
30S ribosomal 
protein S6 
14 17677.3 16146.67 
-



































































22 6571.44 6571.4 -0.04 
8.29E-
15 P0AC92 Protein gnsA 





15 7261.83 7130.83 -131 2.9E-09 P64476 
Uncharacterize
d protein ydiH 
40 7268.98 7268.97 -0.01 3.5E-21 P0A7M7 
50S ribosomal 
protein L29 




d protein yaiA 



















d protein yibT 




























34 protein YejL 






















d protein yebV 




d protein ydcH 





















59 9379.81 9395.79 15.98 
2.93E-
52 P0AB63 Protein yciN 











37 9628.81 9313.62 -315.19 1.8E-23 C5A095 
Cell division 
protein ZapB 





17 9889.14 10291.63 402.49 5.5E-15 P75694 
Uncharacterize
d protein YahO 










57 10595.4 10595.4 0 
1.24E-
47 P0AB55 Protein yciI 






































d protein yqjD 
18 11159.6 11028.56 -131.04 
4.29E-
14 C4ZR49 Protein hfq 











37 11799.1 11666.07 -133.03 
1.32E-
24 P0AA25 Thioredoxin-1 




















22 P0ADU5 Protein ygiW 













18 20832.4 20701.44 -130.96 
3.33E-
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